Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2019	Jan. 31, 2020	Jun. 28, 2019
Cover [Abstract]
Entity Registrant Name	The Manitowoc Company, Inc.
Entity Central Index Key	0000061986
Trading Symbol	MTW
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 621.3
Entity Shares Outstanding		35,376,787
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity File Number	1-11978
Entity Tax Identification Number	39-0448110
Entity Address, Address Line One	11270 West Park Place
Entity Address, Address Line Two	Suite 1000
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53224
City Area Code	414
Local Phone Number	760-4600
Entity Incorporation, State or Country Code	WI
Title of 12(b) Security	Common Stock, $.01 Par Value
Security Exchange Name	NYSE
Entity Interactive Data Current	Yes
Document Annual Report	true
Document Transition Report	false
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for the 2020 Annual Meeting of Shareholders, are incorporated by reference in Part III of this Annual Report on Form 10-K.

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Net sales	$ 1,834.1	$ 1,846.8	$ 1,581.3
Cost of sales	1,490.0	1,518.7	1,299.4
Gross profit	344.1	328.1	281.9
Operating costs and expenses:
Engineering, selling and administrative expenses	225.6	251.6	245.3
Asset impairment expense	0.0	82.6	0.1
Amortization of intangible assets	0.3	0.3	0.8
Restructuring expense	9.8	12.9	27.2
Other operating expenses	0.0	0.0	0.1
Total operating costs and expenses	235.7	347.4	273.5
Operating income (loss)	108.4	(19.3)	8.4
Other income (expense):
Interest expense	(32.7)	(39.1)	(39.2)
Amortization of deferred financing fees	(1.5)	(1.8)	(1.9)
Loss on debt extinguishment	(25.0)	0.0	0.0
Other income (expense) — net	9.8	(11.5)	(6.8)
Total other expense	(49.4)	(52.4)	(47.9)
Income (loss) from continuing operations before income taxes	59.0	(71.7)	(39.5)
Provision (benefit) for income taxes	12.4	(4.8)	(49.5)
Net income (loss) from continuing operations	46.6	(66.9)	10.0
Discontinued operations:
Loss from discontinued operations, net of income taxes of $0.0, $0.0 and $0.0, respectively	0.0	(0.2)	(0.6)
Net income (loss)	$ 46.6	$ (67.1)	$ 9.4
Basic net income (loss) per common share:
Net income (loss) from continuing operations	$ 1.31	$ (1.88)	$ 0.28
Loss from discontinued operations	0	(0.01)	(0.02)
Basic net income (loss) per share	1.31	(1.89)	0.26
Diluted net income (loss) per common share:
Net income (loss) from continuing operations	1.31	(1.88)	0.28
Loss from discontinued operations	0	(0.01)	(0.02)
Diluted net income (loss) per share	$ 1.31	$ (1.89)	$ 0.26

Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Loss from discontinued operations, income taxes	$ 0.0	$ 0.0	$ 0.0

Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.

+ References + Details

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement Of Income And Comprehensive Income [Abstract]
Net income (loss)	$ 46.6	$ (67.1)	$ 9.4
Other comprehensive income (loss), net of income tax:
Net unrealized gains (losses) on derivatives, net of income tax provision of $0.0, $0.0 and $0.0, respectively	0.3	(0.4)	0.4
Employee pension and postretirement benefit income (loss), net of income tax benefit of $0.2, $1.4 and $4.2, respectively	(3.7)	8.9	6.7
Foreign currency translation adjustments	(1.0)	(27.7)	58.4
Total other comprehensive income (loss), net of income tax	(4.4)	(19.2)	65.5
Comprehensive income (loss)	$ 42.2	$ (86.3)	$ 74.9

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statement Of Income And Comprehensive Income [Abstract]
Unrealized income (loss) on derivatives, net of income tax provision	$ 0.0	$ 0.0	$ 0.0
Employee pension and post retirement benefit income (loss), net of income tax benefit	$ 0.2	$ 1.4	$ 4.2

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 199.3	$ 140.3
Accounts receivable, less allowances of $7.9 and $10.3, respectively	168.3	171.8
Inventories — net	461.4	453.1
Notes receivable — net	17.4	19.4
Other current assets	26.0	58.3
Total current assets	872.4	842.9
Property, plant and equipment — net	289.9	288.9
Operating lease right-of-use assets	47.6
Goodwill	232.5	232.8
Other intangible assets — net	116.3	118.1
Other non-current assets	59.0	59.2
Total assets	1,617.7	1,541.9
Current Liabilities:
Accounts payable and accrued expenses	340.8	425.2
Short-term borrowings and current portion of long-term debt	3.8	6.4
Product warranties	47.2	39.1
Customer advances	25.8	9.6
Other liabilities	23.3	16.3
Total current liabilities	440.9	496.6
Non-Current Liabilities:
Long-term debt	308.4	266.7
Operating lease liabilities	37.6
Deferred income taxes	5.5	5.7
Pension obligations	86.4	85.7
Postretirement health and other benefit obligations	16.4	18.3
Long-term deferred revenue	30.3	25.2
Other non-current liabilities	46.3	42.4
Total non-current liabilities	530.9	444.0
Commitments and contingencies (Note 18)
Total stockholders' equity:
Preferred stock (3,500,000 shares authorized of $.01 par value; none outstanding)
Common stock (75,000,000 shares authorized, 40,793,983 shares issued, 35,374,537 and 35,588,833 shares outstanding, respectively)	0.4	0.4
Additional paid-in capital	592.2	584.8
Accumulated other comprehensive loss	(121.0)	(116.6)
Retained earnings	236.2	189.6
Treasury stock, at cost (5,419,446 and 5,205,150 shares, respectively)	(61.9)	(56.9)
Total stockholders’ equity	645.9	601.3
Total liabilities and stockholders' equity	$ 1,617.7	$ 1,541.9

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Accounts Receivable, allowances (in dollars)	$ 7.9	$ 10.3
Preferred stock authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Common stock, shares issued (in shares)	40,793,983	40,793,983
Common stock, shares outstanding (in shares)	35,374,537	35,588,833
Treasury stock (in shares)	5,419,446	5,205,150

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash Flows From Operating Activities
Net income (loss)	$ 46.6	$ (67.1)	$ 9.4
Adjustments to reconcile net income (loss) to cash (used for) provided by operating activities of continuing operations:
Asset impairment expense	0.0	82.6	0.1
Loss from discontinued operations, net of income taxes		0.2	0.6
Depreciation expense	35.0	36.1	38.1
Amortization of intangible assets	0.3	0.3	0.8
Amortization of deferred financing fees	1.5	1.8	1.9
Deferred income tax (benefit) - net	1.5	(11.1)	(44.1)
Loss on early extinguishment of debt	25.0	0.0	0.0
Loss (gain) on sale of property, plant and equipment	(3.5)	0.9	0.1
Stock-based compensation expense and other	10.1	7.4	8.5
Changes in operating assets and liabilities, excluding the effects of business divestitures:
Accounts receivable	(124.2)	(553.4)	(435.5)
Inventories	(18.3)	(72.7)	51.1
Notes receivable	2.9	18.6	18.8
Other assets	23.9	2.7	4.0
Accounts payable	(59.7)	56.5	27.1
Accrued expenses and other liabilities	5.6	(15.6)	(5.2)
Net cash used for operating activities of continuing operations	(53.3)	(512.8)	(324.3)
Net cash used for operating activities of discontinued operations		(0.2)	(0.6)
Net cash used for operating activities	(53.3)	(513.0)	(324.9)
Cash Flows From Investing Activities
Capital expenditures	(35.1)	(31.7)	(28.9)
Proceeds from sale of property, plant and equipment	17.2	13.0	7.0
Cash receipts on sold accounts receivable	126.3	553.1	402.8
Other			0.4
Net cash provided by investing activities	108.4	534.4	381.3
Cash Flows From Financing Activities
Proceeds from revolving credit facility	139.7
Payments on revolving credit facility	(139.7)
Payments on long-term debt	(276.6)	(3.8)	(10.9)
Proceeds from long-term debt	300.0		0.2
Other debt - net	(4.4)		(4.7)
Debt issuance costs	(8.3)
Exercises of stock options including windfall tax benefits	0.4	2.5	5.7
Common stock repurchases	(7.4)
Net cash provided by (used for) financing activities	3.7	(1.3)	(9.7)
Effect of exchange rate changes on cash	0.2	(2.8)	2.4
Net increase (decrease) in cash, cash equivalents and restricted cash	59.0	17.3	49.1
Cash and cash equivalents at beginning of period	140.3	123.0	73.9
Cash and cash equivalents at end of period	199.3	140.3	123.0
Supplemental Cash Flow Information
Interest paid	36.0	36.8	37.0
Income taxes (refunded) paid	$ 10.5	$ 2.6	$ (7.6)

Consolidated Statements of Equity - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings	Treasury Stock
Balance at beginning of year at Dec. 31, 2016		$ 1.4	$ 567.6	$ (162.9)	$ 247.3	$ (62.9)
Balance (in shares) at Dec. 31, 2016		34,960,303
Increase (Decrease) in Stockholders' Equity
Adjustment due to reverse stock split		$ (1.0)	1.0
Stock options exercised and issuance of other stock awards			2.0			3.1
Stock options exercised (in shares)		262,118
Restricted stock, net (in shares)		23,566
Performance shares issued (in shares)		27,877
Stock-based compensation			7.0
Other comprehensive income (loss)				65.5
Net income (loss)	$ 9.4				9.4
Balance at end of year at Dec. 31, 2017	677.5	$ 0.4	577.6	(97.4)	256.7	(59.8)
Balance (in shares) at Dec. 31, 2017		35,273,864
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(1.0)			2.9
Stock options exercised (in shares)		95,019
Restricted stock, net (in shares)		165,404
Performance shares issued (in shares)		54,546
Stock-based compensation			8.2
Other comprehensive income (loss)				(19.2)
Net income (loss)	(67.1)				(67.1)
Balance at end of year at Dec. 31, 2018	601.3	$ 0.4	584.8	(116.6)	189.6	(56.9)
Balance (in shares) at Dec. 31, 2018		35,588,833
Increase (Decrease) in Stockholders' Equity
Stock options exercised and issuance of other stock awards			(2.1)			2.4
Stock options exercised (in shares)		58,404
Restricted stock, net (in shares)		145,482
Performance shares issued (in shares)		54,860
Common stock repurchases (in shares)		(473,042)
Common stock repurchases		$ 7.4				(7.4)
Stock-based compensation			9.5
Other comprehensive income (loss)				(4.4)
Net income (loss)	46.6				46.6
Balance at end of year at Dec. 31, 2019	$ 645.9	$ 0.4	$ 592.2	$ (121.0)	$ 236.2	$ (61.9)
Balance (in shares) at Dec. 31, 2019		35,374,537

Consolidated Statements of Equity (Parenthetical)	12 Months Ended
Consolidated Statements of Equity (Parenthetical)	Dec. 31, 2017
Statement Of Stockholders Equity [Abstract]
Reverse stock split	4

Company and Basis of Presentation

12 Months Ended

Dec. 31, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Company and Basis of Presentation

1. Company and Basis of Presentation

The Manitowoc Company, Inc. (“Manitowoc” and the “Company”) was founded in 1902 and has over a 117-year tradition of providing high-quality, customer-focused products and support services to its markets. Manitowoc is one of the world’s leading providers of engineered lifting solutions. Manitowoc, through its wholly-owned subsidiaries, designs, manufactures, markets, and supports comprehensive product lines of mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks under the Grove, Manitowoc, National Crane, Potain, Shuttlelift and Manitowoc Crane Care brand names. The Company serves a wide variety of customers, including dealers, rental companies, contractors, and government entities, across the petrochemical, industrial, commercial construction, power and utilities, infrastructure and residential construction end markets. Additionally, its Manitowoc Crane Care offering leverages Manitowoc's installed base of approximately 149,000 cranes to provide aftermarket parts and services to enable its customers to manage their fleets more effectively and improve their return on investment. Due to the ongoing and predictable maintenance needed by cranes, as well as the high cost of crane downtime, Manitowoc Crane Care provides the Company with a consistent stream of recurring revenue. Manitowoc is a Wisconsin corporation and its principal executive offices are located at 11270 West Park Place Suite 1000, Milwaukee, Wisconsin 53224.

Basis of Presentation The consolidated financial statements include the accounts of The Manitowoc Company, Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.

Certain prior period amounts have been reclassified to conform to the current period presentation. All amounts, except per share and share amounts, are in millions of dollars throughout the tables in these notes unless otherwise indicated.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents.

Allowance for Doubtful Accounts Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Our estimate for the allowance for doubtful accounts related to trade receivables includes evaluation of specific accounts where we have information that the customer may have an inability to meet its financial obligations together with a general provision for unknown but existing doubtful accounts based on historical experience, which are subject to change if experience improves or deteriorates.

Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out method.

Goodwill and Other Intangible Assets The Company accounts for goodwill and other intangible assets under the guidance of Accounting Standards Codification (“ASC”) Topic 350-10, “Intangibles — Goodwill and Other.” Under ASC Topic 350-10, goodwill is not amortized; instead, the Company performs an annual impairment review. The date for the annual impairment review is October 31, or more frequently if events or changes in circumstances indicate that the assets might be impaired. To test goodwill, the Company estimates the fair values of its reporting units using the income approach based on the present value of expected future cash flows, subject to a comparison for reasonableness to its market capitalization at the date of valuation. If the carrying amount exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of the goodwill. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value.

The Company’s other intangible assets with indefinite lives, including trademarks and tradenames and distribution networks, are not amortized but are tested for impairment annually, or more frequently, as events dictate. For other indefinite lived intangible assets, the impairment test consists of a comparison of the fair value of the intangible assets to their carrying amount. See Note 9, “Goodwill and Other Intangible Assets,” for further details on our impairment assessments. The Company’s intangible assets subject to amortization are tested for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable.

The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives:

		Useful lives
Patents		20 years
Customer relationships		20 years

Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance, repairs and minor renewals are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and are then depreciated. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the estimated useful lives of the assets using the straight-line depreciation method for financial reporting and accelerated depreciation methods for income tax purposes.

Property, plant and equipment are depreciated over the following estimated useful lives:

		Years
Building and improvements		2 - 43
Machinery, equipment and tooling		3 - 18
Furniture and fixtures		3 - 10
Computer hardware and software		2 - 10
Rental cranes		5 - 15

Property, plant and equipment also includes cranes accounted for as operating leases. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer has a significant economic incentive of exercising. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of buyback and rental equipment included in property, plant and equipment amounted to $51.2 million and $49.4 million, net of accumulated depreciation, at December 31, 2019 and 2018, respectively.

The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If an impairment is determined to exist, any related impairment loss is calculated based upon comparison of the expected undiscounted future cash flows to the net book value of the assets.

Warranties Estimated standard manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs related to the extended warranty are expensed as incurred.

Product Liabilities The Company records product liability reserves for its self-insured portion of any pending or threatened product liability actions when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding pending and threatened product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates.

Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments

to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC No. 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge.

The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates.

The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes.

Stock-Based Compensation The Company recognizes expense for all stock-based compensation with graded vesting on a straight-line basis over the vesting period of the entire award. Stock-based compensation plans are described more fully in Note 16, “Stock-Based Compensation.”

Research and Development Research and development costs are charged to expense as incurred and amounted to $31.1 million, $35.2 million and $37.9 million for the years ended December 31, 2019, 2018 and 2017, respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs.

Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority.

Earnings Per Share Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted earnings (loss) per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards.

Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net earnings, other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments.

Recent Accounting Changes and Pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 “Income Taxes (Topic 740).” The amendments in this ASU simplify accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The standard is effective for annual periods beginning after December 15, 2020. The Company is currently evaluating the impact the adoption of the ASU will have on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15 “Intangibles – Goodwill and Other – Internal-use Software (Subtopic 250-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.” The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The standard is effective for annual periods beginning after December 15, 2019. The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02 “Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This new standard permits an entity to reclassify to retained earnings the tax effects stranded in accumulated other comprehensive income (loss) as a result of U.S. tax reform. The Company adopted this ASU as of January 1, 2019 and chose not to reclassify the stranded tax effects related to the U.S. tax reform change in the federal corporate tax rate from accumulated other comprehensive income (loss) to retained earnings. The Company has elected the portfolio approach to release stranded income tax effects in accumulated other comprehensive income (loss).

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses,” which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. The new guidance is applicable to financial assets measured at amortized cost, net investments in leases and certain off-balance sheet credit exposures. The standard is effective for annual periods beginning after December 15, 2019. The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02 - “Leases,” which is intended to improve financial reporting on leasing transactions. This was further clarified with technical corrections issued within ASU 2018-10 and ASU 2018-11. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. The Company adopted this ASU as of January 1, 2019. The adoption of this ASU did not have a material impact on the Company’s Consolidated Statement of Operations and Consolidated Statement of Cash Flows. The updated disclosures are included in Note 22, “Leases.”

Revenues

12 Months Ended

Dec. 31, 2019

Revenue From Contract With Customer [Abstract]

Revenues

3. Revenues

Significant Accounting Policy

Revenue is recognized when obligations under the terms of a contract with the Company’s customer are satisfied; generally this occurs with the transfer of control of the Company’s cranes or aftermarket parts or completion of performance of services. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. The Company recognizes revenue for extended warranties beyond the base warranties over the life of the extended warranty period.

Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from revenue.

Shipping and handling costs associated with outbound freight after control over a product has transferred to a customer are categorized as a fulfillment cost and are included in cost of sales on the Consolidated Statement of Operations.

Performance Obligations

The following is a description of principle activities from which the Company generates revenue. Disaggregation of the Company’s revenue sources are disclosed in Note 17, “Segments.”

Crane Revenue

Crane revenue is primarily generated through the sale of new and used cranes. Contracts with customers are generally in the form of a purchase order. Based on the nature of the Company’s contracts, the Company does not have any significant financing terms. Contracts may have variable consideration in the form of early pay discounts or rebates, however the variable consideration is not material to the overall contract with the customer. Revenue is earned under these contracts when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier or acceptance through an independent inspection company that acts as an agent of the customer.

Given the nature of the Company’s products, from time to time, the customer may request that the product be held until a delivery location is identified. Under these “bill and hold” arrangements, revenue is recognized when all of the following criteria are met: 1) the reason for the bill-and-hold arrangement is substantive, 2) the product is separately identified as belonging to the customer, 3) the product is ready for transfer to the customer, and 4) the Company does not have the ability to use the product or direct it to another customer.

From time to time, the Company enters into agreements where the customer has the right to exercise a buyback option for the repurchase of a crane by the Company at an agreed upon price. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise that right. If it is determined that the customer has a significant economic incentive to exercise that right, the agreement is accounted for as a lease in accordance with ASC Topic 842 “Leases” (“Topic 842”). If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the asset is transferred to the customer. Refer to Note 19, “Guarantees” for additional information.

Aftermarket Part Sales

Aftermarket part sales are generated through the sale of new and used parts to end customers and distributors. Aftermarket parts revenue is recognized when control of the product is transferred to the customer. Control transfers to the customer generally upon delivery to the carrier. Customers generally have a right of return which the Company estimates using historical information. The amount of estimated returns is deducted from revenue.

Other Revenues

The Company’s other revenues consist primarily of revenues from:

•

Repair and field service work; and

•

Training and technical publications.

As it relates to the Company’s other revenues, the Company’s performance obligations generally relate to performing specific agreed upon services. Revenue is earned upon the completion of those services.

Customer Advances

The Company records deferred revenue when cash payments are received or due in advance of performance, including amounts which are refundable. The table below shows the change in the customer advances balance for the year ended December 31, 2019 and 2018 which are included in current liabilities in the Consolidated Balance Sheet.

	2019			2018
Balance at beginning of period	$	9.6		$	12.7
Cash received in advance of satisfying performance obligation		112.2			96.5
Revenue recognized		(96.3	)		(98.5	)
Currency translation		0.3			(1.1	)
Balance at end of period	$	25.8		$	9.6

Practical Expedients and Exemptions

The Company expenses sales commissions when incurred because the amortization period would be one year or less. These costs are recorded within engineering, selling and administrative expenses in the Consolidated Statement of Operations.

The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed.

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

4. Fair Value of Financial Instruments

ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820-10 classifies the inputs used to measure fair value into the following hierarchy:

Level 1

Unadjusted quoted prices in active markets for identical assets or liabilities

Level 2

Unadjusted quoted prices in active markets for similar assets or liabilities, or

Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or

Inputs other than quoted prices that are observable for the asset or liability

Level 3

Unobservable inputs for the asset or liability

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2019 and 2018 by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

	Fair Value as of December 31, 2019
	Level 1		Level 2		Level 3		Total
Current Assets:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1
Current Liabilities:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1

	Fair Value as of December 31, 2018
	Level 1		Level 2		Level 3		Total
Current Assets:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1
Current Liabilities:
FX Forward Contracts	$	—	$	1.8	$	—	$	1.8

The fair value of the senior secured second lien notes due on April 1, 2026, with an annual coupon rate of 9.000% (the “2026 Notes”), was approximately $316.1 million as of December 31, 2019.

The Company endeavors to utilize the best available information in measuring fair value. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company estimates fair value of its 2026 Notes based on quoted market prices of the instruments; because these markets are typically actively traded, the liabilities are classified as Level 1 within the valuation hierarchy. The carrying values of cash and cash equivalents, accounts receivable, accounts payable, deferred purchase price notes on receivables sold (see Note 12, “Accounts Receivable Securitization and Other Factoring Arrangements”) and short-term variable debt, including any amounts outstanding under our revolving credit facility, approximate fair value, without being discounted as of December 31, 2019 due to the short-term nature of these instruments.

FX Forward Contracts are valued through an independent valuation source which uses an industry standard data provider, with resulting valuations periodically validated through third-party or counterparty quotes. As such, these derivative instruments are classified within Level 2. See Note 5, “Derivative Financial Instruments” for additional information.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Derivative Financial Instruments

12 Months Ended

Dec. 31, 2019

Derivative Instruments And Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

5. Derivative Financial Instruments

The Company’s risk management objective is to ensure that business exposures to risks are minimized using the most effective and efficient methods to eliminate, reduce, or transfer such exposures. Operating decisions consider these associated risks and, whenever possible, transactions are structured to avoid or mitigate these risks.

From time to time, the Company enters into FX Forward Contracts to manage the exposure on forecasted transactions denominated in non-functional currencies and to manage the risk of transaction gains and losses associated with assets/liabilities in currencies other than the functional currency of certain subsidiaries. Certain of these FX Forward Contracts are designated as cash flow hedges. To the extent these derivatives are effective in offsetting the variability of the hedged cash flows, changes in the derivatives’ fair value are not included in current earnings but are included in accumulated other comprehensive income (loss). These changes in fair value are reclassified into earnings as a component of cost of sales, as applicable, when the forecasted transaction impacts earnings. In addition, if the forecasted transaction is no longer probable, the cumulative change in the derivatives’ fair value is recorded as a component of other income (expense) – net in the period in which the transaction is no longer considered probable of occurring. No amounts were recorded related to these types of transactions during the years ended December 31, 2019, 2018 and 2017.

The Company had FX Forward Contracts with an aggregate notional amount of $32.6 million and $76.8 million outstanding as of December 31, 2019 and 2018, respectively. The aggregate notional amount outstanding as of December 31, 2019 is scheduled to mature within one year. The FX Forward Contracts purchased are denominated in Euros. As of December 31, 2019 and 2018, the fair value of these contracts was a net zero balance and a net current liability of $1.7 million, respectively. Net unrealized gains (losses), net of income tax, recorded in accumulated other comprehensive income (loss) were zero and $(0.3) million as of December 31, 2019 and 2018, respectively.

The following table provides the amount of gains or losses recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2019 and 2018.

	Recognized Location	2019		2018			2017
Designated	Cost of sales	$	3.1	$	5.0		$	0.6
Non-Designated	Other income (expense) - net		3.9		(1.9	)		(0.8	)

Inventories

12 Months Ended

Dec. 31, 2019

Inventory Disclosure [Abstract]

Inventories

6. Inventories

The components of inventories as of December 31, 2019 and 2018 are summarized as follows:

	2019			2018
Raw materials	$	156.3		$	159.2
Work-in-process		116.3			112.0
Finished goods		239.4			238.0
Total inventories		512.0			509.2
Excess and obsolete inventory reserve		(50.6	)		(56.1	)
Inventories — net	$	461.4		$	453.1

Notes Receivable

12 Months Ended

Dec. 31, 2019

Receivables [Abstract]

Notes Receivable

7. Notes Receivable

The Company has notes receivable balances that are classified as current or long-term based on the timing of the amounts due. Long-term notes receivable are included within other non-current assets on the Consolidated Balance Sheet. Current and long-term notes receivable balances primarily relate to the Company's captive finance entity in China. The Company also has a long-term note receivable balance related to the 2014 sale of Manitowoc Dong Yue. During 2019 and 2018, the Company recorded $2.8 million and $3.6 million, respectively, related to the write down of the note with Manitowoc Dong Yue to the anticipated collection amount based on current expectations. As of December 31, 2019, the Company had current and long-term notes receivable in the amounts of $17.4 million and $16.3 million, respectively. As of December 31, 2018, the Company had current and long-term notes receivable in the amounts of $19.4 million and $17.0 million, respectively.

Property, Plant and Equipment

12 Months Ended

Dec. 31, 2019

Property Plant And Equipment [Abstract]

Property, Plant and Equipment

8. Property, Plant and Equipment

The components of property, plant and equipment as of December 31, 2019 and 2018 are summarized as follows:

	2019			2018
Land	$	24.0		$	24.1
Building and improvements		197.3			195.3
Machinery, equipment and tooling		274.2			269.4
Furniture and fixtures		18.5			16.4
Computer hardware and software		119.3			117.1
Rental cranes		77.7			84.0
Construction in progress		11.2			9.6
Total cost		722.2			715.9
Less accumulated depreciation		(432.3	)		(427.0	)
Property, plant and equipment — net	$	289.9		$	288.9

The Company recorded no asset impairment charges for the year ended December 31, 2019. For the year ended December 31, 2018, the Company recorded $0.4 million in asset impairment charges.

Assets Held for Sale

As of December 31, 2018, the Company had classified $12.9 million as assets held for sale within other current assets on the Consolidated Balance Sheets related to the Manitowoc, Wisconsin manufacturing buildings and land. During 2019, the Company sold the Manitowoc, Wisconsin manufacturing buildings and land previously classified as assets held for sale, which resulted in a $3.5 million gain recorded within other income (expense) – net on the Consolidated Statements of Operations.

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2019

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

9. Goodwill and Other Intangible Assets

The Company performs its annual goodwill and indefinite lived assets impairment testing during the fourth quarter. Based on the results of that test, no impairment was indicated in 2019. The Company will continue to monitor changes in circumstances and test more frequently if those changes indicate that assets might be impaired.

During the year ended December 31, 2018, the Company recorded a non-cash goodwill impairment charge of $82.2 million in the EURAF reporting unit. The goodwill impairment charge resulted from a reduction in the estimated fair value of the reporting unit based on the continued decline in the Company’s equity market capitalization and lower forecasted results in the region.

A considerable amount of management judgment and assumptions are required in performing the impairment tests as it relates to revenue growth rates and projected operating income. While the Company believes the judgments and assumptions are reasonable, different assumptions could change the estimated fair value and, therefore, additional impairment charges could be required. Weakening industry or economic trends, disruptions to our business, unexpected significant changes or planned changes in the use of the assets or in entity structure may adversely impact the assumptions used in the valuations. The Company continually monitors market conditions and determines if any additional interim reviews of goodwill, other intangibles or long-lived assets are warranted. In the event the Company determines that assets are impaired in the future, the Company would recognize a non-cash impairment charge, which could have a material adverse effect on the Company’s Consolidated Balance Sheets and Results of Operations.

The changes in carrying amount of goodwill for the years ended December 31, 2019 and 2018 are as follows:

	Americas		EURAF			MEAP			Consolidated
Balance as of January 1, 2018	$	166.5	$	85.9		$	68.9		$	321.3
Foreign currency impact		—		(3.7	)		(2.6	)		(6.3	)
Goodwill impairment		—		(82.2	)		—			(82.2	)
Net balance as of December 31, 2018		166.5		—			66.3			232.8
Foreign currency impact		—		—			(0.3	)		(0.3	)
Net balance as of December 31, 2019	$	166.5	$	—		$	66.0		$	232.5

The gross carrying amount and accumulated amortization of the Company’s intangible assets other than goodwill are as follows as of December 31, 2019 and 2018.

	December 31, 2019							December 31, 2018
	Gross Carrying Amount		Accumulated Amortization Amount			Net Book Value		Gross Carrying Amount		Accumulated Amortization Amount			Net Book Value
Trademarks and tradenames	$	95.3	$	—		$	95.3	$	96.7	$	—		$	96.7
Customer relationships		10.0		(8.5	)		1.5		10.1		(8.4	)		1.7
Patents		29.5		(28.7	)		0.8		29.8		(29.0	)		0.8
Distribution network		18.7		—			18.7		18.9		—			18.9
Net balance	$	153.5	$	(37.2	)	$	116.3	$	155.5	$	(37.4	)	$	118.1

Amortization of intangible assets for the years ended December 31, 2019, 2018 and 2017 was $0.3 million, $0.3 million and $0.8 million, respectively. Excluding the impact of any future acquisitions, divestitures or impairments, the Company anticipates amortization will be approximately $0.3 million per year through 2022.

Accounts Payable and Accrued Expenses

12 Months Ended

Dec. 31, 2019

Payables And Accruals [Abstract]

Accounts Payable and Accrued Expenses

10. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses as of December 31, 2019 and 2018 are summarized as follows:

	2019		2018
Trade accounts payable	$	187.1	$	249.2
Employee-related expenses		56.6		59.5
Accrued vacation		20.2		24.3
Miscellaneous accrued expenses		76.9		92.2
Total accounts payable and accrued expenses	$	340.8	$	425.2

Debt

12 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Debt

11. Debt

Outstanding debt as of December 31, 2019 and 2018 is summarized as follows:

	2019			2018
Senior secured asset based revolving credit facility	$	—		$	—
Senior secured second lien notes due 2021		—			254.2
Senior secured second lien notes due 2026		300.0			—
Other		16.7			21.2
Deferred financing costs		(4.5	)		(2.3	)
Total debt		312.2			273.1
Short-term borrowings and current portion of long-term debt		(3.8	)		(6.4	)
Long-term debt	$	308.4		$	266.7

On March 25, 2019, the Company and certain of its subsidiaries entered into an indenture with U.S. Bank National Association as trustee and notes collateral agent, pursuant to which the Company issued $300.0 million aggregate principal amount of senior secured second lien notes due on April 1, 2026 with an annual coupon rate of 9.000%. Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year. The 2026 Notes are fully and unconditionally guaranteed on a senior secured second lien basis, jointly and severally, by each of the Company’s existing and future domestic subsidiaries that is either a guarantor or a borrower under the ABL Revolving Credit Facility (as defined below) or that guarantees certain other debt of the Company or a guarantor. The 2026 Notes and the related guarantees are secured on a second-priority basis, subject to certain exceptions and permitted liens, by pledges of capital stock and other equity interests and other security interests in substantially all of the personal property and fee-owned real property of the Company and of the guarantors that secure obligations under the ABL Revolving Credit Facility. The 2026 Notes were sold pursuant to exemptions from registration under the Securities Act of 1933.

Additionally, on March 25, 2019, the Company and certain subsidiaries of the Company (the “Loan Parties”) entered into a credit agreement (the “ABL Credit Agreement”) with JP Morgan Chase Bank, N.A. as administrative and collateral agent, and

certain financial institutions party thereto as lenders, providing for a senior secured asset-based revolving credit facility (the “ABL Revolving Credit Facility”) of up to $275.0 million. The borrowing capacity under the ABL Revolving Credit Facility is based on the value of inventory, accounts receivable and fixed assets of the Loan Parties. The Loan Parties’ obligations under the ABL Revolving Credit Facility are secured on a first-priority basis, subject to certain exceptions and permitted liens, by substantially all of the personal property and fee-owned real property of the Loan Parties. The liens securing the ABL Revolving Credit Facility are senior in priority to the second-priority liens securing the obligations under the 2026 Notes and the related guarantees. The ABL Revolving Credit Facility has a term of 5 years and includes a $75.0 million letter of credit sub-facility, $10.0 million of which is available to the Company’s German subsidiary that is a borrower under the ABL Revolving Credit Facility.

Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or the Eurodollar and Overnight London Interbank Offer Rate (“LIBOR”). The variable interest rate is based upon the average quarterly availability as of the most recent determination date as follows:

Average quarterly availability	Alternative base rate spread	Eurodollar and overnight LIBOR spread
≥ 50% of Aggregate Commitment	0.25%	1.25%
< 50% of Aggregate Commitment	0.50%	1.50%

The Company used the initial extension credit under the ABL Revolving Credit Facility, together with the net proceeds from the offering of the 2026 Notes, to (i) redeem all of the Company’s $260.0 million in outstanding 12.750% Senior Secured Second Lien Notes due 2021 (the “Prior 2021 Notes”); (ii) repay all obligations outstanding, and terminate all commitments, under (x) the Company’s previous $225.0 million ABL Revolving Credit Facility (“Prior ABL Facility”) and (y) $75.0 million AR Securitization Facility; and (iii) pay related fees and expenses, including $16.6 million of call premium on the Prior 2021 Notes, $5.0 million of closing costs and $4.6 million of accrued interest.

During the year ended December 31, 2019, the Company recorded a $25.0 million charge in the Consolidated Statement of Operations associated with the Company’s refinancing of the ABL Revolving Credit Facility and 2026 Notes. The charge is composed of $16.6 million of call premium on the Prior 2021 Notes, $5.3 million of unamortized discount on the Prior 2021 Notes and $3.1 million of unamortized debt issuance costs.

As of December 31, 2019, the Company had outstanding $16.7 million of other indebtedness that has a weighted-average interest rate of approximately 5.1%. This debt includes balances on local credit lines and other financing arrangements obligations.

As of December 31, 2019, the Company did not have an outstanding balance on the ABL Revolving Credit Facility and no borrowings on the Prior ABL Facility as of December 31, 2018. During the year ended December 31, 2019, the highest daily borrowing under either ABL facility was $39.7 million and the average borrowing was $8.9 million, while the average annual interest rate was 4.15%. The interest rate of the ABL Revolving Credit Facility fluctuates based on excess availability. As of December 31, 2019, the spreads for Eurodollar and Overnight LIBOR and Alternative Base Rate borrowings were 1.25% and 0.25%, respectively, with excess availability of approximately $206.4 million, which represents revolver borrowing capacity of $210.4 million less U.S. letters of credit outstanding of $4.0 million.

Both the ABL Revolving Credit Facility and 2026 Notes include customary covenants which include, without limitation, restrictions on, the Company’s ability and the ability of the Company’s restricted subsidiaries to incur, assume or guarantee additional debt or issue certain preferred shares, pay dividends on or make other distributions in respect of the Company’s capital stock or make other restricted payments, make certain investments, sell or transfer certain assets, create liens on certain assets to secure debt, consolidate, merge, sell, or otherwise dispose of all or substantially all of the Company’s assets, enter into certain transactions with affiliates and designate the Company’s subsidiaries as unrestricted. Both the ABL Revolving Credit Facility and the 2026 Notes also include customary events of default.

Additionally, the ABL Revolving Credit Facility contains a covenant requiring the Company to maintain a minimum fixed charge coverage ratio under certain circumstances set forth in the ABL Credit Agreement.

The aggregate scheduled future maturities of outstanding debt obligations as of December 31, 2019 is as follows:

Year
2020	$	3.8
2021		10.5
2022		1.7
2023		—
2024		—
Thereafter		300.7
Total	$	316.7

•

The table of scheduled maturities above does not agree to the Company’s total debt as of December 31, 2019 as shown on the Consolidated Balance Sheet due to $4.5 million of deferred financing costs.

As of December 31, 2019, the Company was in compliance with all affirmative and negative covenants in its debt instruments, inclusive of the financial covenants pertaining to the ABL Revolving Credit Facility and 2026 Notes. Based upon management’s current plans and outlook, the Company believes it will be able to comply with these covenants during the subsequent twelve months.

Accounts Receivable Securitization and Other Factoring Arrangements

12 Months Ended

Dec. 31, 2019

Transfers And Servicing [Abstract]

Accounts Receivable Securitization and Other Factoring Arrangements

12. Accounts Receivable Securitization and Other Factoring Arrangements

The Company had maintained a Receivables Purchase Agreement (“RPA”) among Manitowoc Funding, LLC (“MTW Funding”), as Seller, The Manitowoc Company, Inc., as Servicer, and Wells Fargo Bank, N.A., as Purchaser and as Agent, with a commitment size of $75.0 million. Under the RPA (and the related Purchase and Sale Agreements referenced in the RPA), the Company’s domestic trade accounts receivable were sold to MTW Funding which, in turn, sold, conveyed, transferred and assigned to a third-party financial institution (“Purchaser”), all of MTW Funding’s rights, title and interest in a pool of receivables to the Purchaser. Transactions under the program are accounted for as sales in accordance with ASC Topic 860, “Transfers and Servicing” (“Topic 860”). This program was terminated on March 25, 2019.

Trade accounts receivables sold to the Purchaser and being serviced by the Company totaled $149.0 million and $863.5 million as of December 31, 2019 and 2018, respectively. Cash proceeds received from customers related to the receivables previously sold for the years ended December 31, 2019 and 2018 were $182.8 million and $781.6 million, respectively.

Sales of trade receivables under the program reflected as a reduction of accounts receivable in the accompanying Consolidated Balance Sheets were zero and $75.0 million as of December 31, 2019 and 2018, respectively. The proceeds received, including collections on the deferred purchase price notes, are included in cash flows from operating activities in the accompanying Consolidated Statements of Cash Flows. The Company deems the interest rate risk related to the deferred purchase price notes to be de minimis, primarily because the average collection cycle of the related receivables is less than 60 days; and as such, the fair value of the Company’s deferred purchase price notes approximates book value. The fair value of the deferred purchase price notes recorded as of December 31, 2019 and 2018 was zero and $71.5 million, respectively, and is included in accounts receivable in the accompanying Consolidated Balance Sheets. For the years ended December 31, 2019, 2018 and 2017 non-cash investing activities related to the increase in the deferred purchase price was zero, $594.2 million and $538.1 million, respectively.

The Company has two non-U.S. accounts receivable financing programs. During 2019, the Company increased the maximum availability under these programs from €45 million to €55 million. Under these financing programs, the Company has the ability to sell eligible receivables up to the maximum limit and can sell additional receivables as previously sold are collected. During the year ended December 31, 2019, the Company sold €193.6 million of receivables and received €193.6 million of cash on the sold receivables. The Company also has one U.S. accounts receivable financing program. Transactions under the U.S. and non-U.S. programs were accounted for as sales in accordance with Topic 860.

Income Taxes

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

13. Income Taxes

Income (loss) from continuing operations before income taxes for the years ended December 31, 2019, 2018 and 2017 is summarized as follows:

	2019			2018			2017
Income (loss) from continuing operations before income taxes:
U.S.	$	(10.0	)	$	(76.4	)	$	(98.5	)
Non-U.S.		69.0			4.7			59.0
Total	$	59.0		$	(71.7	)	$	(39.5	)

Income tax provision (benefit) for the years ended December 31, 2019, 2018 and 2017 is summarized as follows:

	2019			2018			2017
Current:
U.S. Federal and state	$	(0.7	)	$	(7.3	)	$	(12.8	)
Non-U.S.		11.6			13.6			7.4
Total current	$	10.9		$	6.3		$	(5.4	)
Deferred:
U.S. Federal and state	$	0.2		$	(6.2	)	$	(7.0	)
Non-U.S.		1.3			(4.9	)		(37.1	)
Total deferred	$	1.5		$	(11.1	)	$	(44.1	)
Income tax provision (benefit)	$	12.4		$	(4.8	)	$	(49.5	)

The U.S. federal statutory income tax rate is reconciled to the Company’s effective income tax rate for continuing operations for the years ended December 31, 2019, 2018 and 2017 as follows:

	2019			2018			2017
U.S. federal income tax at statutory rate		21.0	%		21.0	%		35.0	%
U.S. state income tax provision		(0.2	)		4.3			16.3
Manufacturing & research incentives		(5.2	)		2.4			7.9
Taxes on non-U.S. income which differ from the U.S. statutory rate		(4.4	)		(3.2	)		41.5
Adjustments for unrecognized tax benefits		(2.2	)		9.6			0.5
Adjustments for valuation allowances		7.6			(1.8	)		287.7
U.S. Tax Reform		6.9			2.5			(228.3	)
Goodwill impairment		—			(24.6	)		—
Other items		(2.5	)		(3.6	)		(35.4	)
Effective income tax rate		21.0	%		6.6	%		125.2	%

On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the “Tax Reform Act”). This legislation significantly changed U.S. tax law by, among other things, lowering corporate income tax rates, and imposing a repatriation tax on deemed repatriated earnings of non-U.S. subsidiaries. The Tax Reform Act permanently reduced the U.S. corporate income tax rate from a maximum of 35% to a flat 21% rate, effective January 1, 2018.

The Tax Reform Act provided for a one-time deemed mandatory repatriation of post-1986 undistributed foreign subsidiary earnings and profits through the year ended December 31, 2017. The Transition Tax, which was completed in 2018, resulted in recording a total Transition Tax obligation of $57.2 million, however there was no U.S. cash tax impact due to net operating loss utilization. On January 15, 2019, the U.S. Treasury released final regulations under amended Internal Revenue Code Section 965. The Company accounted for the effects of the new regulations during the first quarter of 2019, the period in which the regulations were issued. There was no material change resulting from application of the new regulations.

Beginning in 2018, the Tax Reform Act includes two new U.S. corporate tax provisions, the global intangible low-taxed income (“GILTI”) and the base-erosion and anti-abuse tax (“BEAT”) provisions. The GILTI provision requires the Company to include in its U.S. income tax return non-U.S. subsidiary earnings in excess of an allowable return on the non-U.S. subsidiary’s tangible

assets. The Company has elected to treat GILTI as a period cost. The BEAT provision in the Tax Reform Act eliminates the deduction of certain base-erosion payments made to related non-U.S. corporations, and imposes a minimum tax if the amount is greater than the regular tax. The Company evaluated the GILTI and BEAT provisions, resulting in no financial statement impact for the year ended December 31, 2019, and $0.0 and $0.4 million, respectively, for the year ended December 31, 2018. While GILTI resulted in an inclusion of non-U.S. earnings of $19.9 and $30.4 million, respectively, for the years ended December 31, 2019 and 2018, because of the Company’s net operating losses and valuation allowance, there was no net financial statement impact.

The 2019 and 2018 effective tax rates were favorably impacted by income earned in jurisdictions where the statutory rate was less than the federal income tax rate of 21%. The 2017 effective tax rates were favorably impacted by income earned in jurisdictions where the statutory rate was less than the federal income tax rate of 35%. The rate reconciling items included above, when adjusted for actual dollar values, are consistent with prior year. The percentage impact is higher in 2017 due to the lower consolidated pretax loss and the higher 2017 U.S. federal rate.

As of each reporting date, the Company's management considers new evidence, both positive and negative, that could impact management's view with regard to future realization of deferred tax assets.

The Company has recorded valuation allowances on the deferred tax assets in Brazil, China Leasing, Germany, India, Netherland Antilles, U.K., and the U.S. as it is more likely than not that they will not be utilized. During 2018, the Company partially released the valuation allowance in the U.K. resulting in a $12.3 million tax benefit. The 2018 tax provision was impacted by a net increase of $1.3 million primarily related to additional valuation allowances recorded in the U.S., partially offset by the U.K. valuation allowance release noted above. The 2019 tax provision was impacted by a net increase of $4.5 million related to additional valuation allowances recorded in the various jurisdictions noted above.

The Company will continue to periodically evaluate its valuation allowance requirements in light of changing facts and circumstances and may adjust its deferred tax asset valuation allowances accordingly. It is reasonably possible that the Company will either add to or reverse a portion of its existing deferred tax asset valuation allowances in the future. Such changes in the deferred tax asset valuation allowances will be reflected in the current operations through the Company’s income tax provision and could have a material effect on operating results.

For 2019, the only significant item included in Other items was the favorable resolution of the German income tax audit. For 2018, the only significant item included in Other items was the $1.7 million of deferred taxes related to the update of the Company’s permanent reinvestment of foreign earnings assertion (discussed further below). For 2017, the only significant item included in Other items was the IRS audit resolution.

Temporary differences and carryforwards that give rise to deferred tax assets and liabilities include the following items:

	2019			2018
Non-current deferred income tax assets (liabilities):
Inventories	$	24.3		$	22.7
Accounts receivable		(3.7	)		(4.2	)
Property, plant and equipment		(8.2	)		(14.0	)
Intangible assets		(34.1	)		(34.8	)
Deferred employee benefits		39.8			40.7
Product warranty reserves		8.6			6.6
Product liability reserves		3.0			4.0
Tax credits		5.4			7.1
Loss and other tax attribute carryforwards		125.7			137.8
Deferred revenue		5.8			5.1
Other		11.9			4.2
Total non-current deferred income tax assets		178.5			175.2
Less valuation allowance		(157.1	)		(153.1	)
Net deferred income tax assets, non-current	$	21.4		$	22.1

The net deferred tax assets are reflected in the Consolidated Balance Sheets for the years ended December 31, 2019 and 2018 as follows:

	2019			2018
Long-term income tax assets, included in other non-current assets	$	26.9		$	27.8
Long-term deferred income tax liability		(5.5	)		(5.7	)
Net deferred income tax asset	$	21.4		$	22.1

With the enactment of the Tax Reform Act, the Company believes that its offshore cash can be accessed in a more tax efficient manner. Therefore, in 2018, the Company updated its assertion that foreign earnings are permanently reinvested such that jurisdictions where cash can be tax efficiently repatriated are no longer permanently reinvested. As of December 31, 2019, $1.8 million of deferred taxes were provided on approximately $255.3 million of unremitted earnings of non-U.S. subsidiaries that may be remitted to the U.S. As of December 31, 2018, $1.7 million of deferred taxes were provided on approximately $322.0 million of unremitted earnings of Non-U.S. subsidiaries that may be remitted to the U.S. The Company has approximately $430.9 million of additional unremitted earnings of non-U.S. subsidiaries for which it has not currently provided deferred taxes, as of December 31, 2019. These earnings, if repatriated to the U.S., would not result in a material tax expense. As of December 31, 2017, the Company did not record a deferred tax liability related to its non-U.S. earnings that could have been remitted. Because of immateriality, the associated deferred tax liability is included with other items on the schedule of temporary differences and carryforwards above.

The Company has approximately $39.5 million of interest expense carryforwards that is not subject to any time restrictions for future use. The utilization of the interest expense carryforwards is annually limited to 30% of adjusted taxable income. The carryforward is offset by a valuation allowance.

The Company has approximately $677.4 million of U.S. state net operating loss carryforwards, which are available to reduce future U.S. state tax liabilities. These U.S. state net operating loss carryforwards expire at various times through 2039. The Company has recorded a full valuation allowance related to the U.S. state net operating losses.

The Company has approximately $327.2 million of non-U.S. loss carryforwards, which are available to reduce future non-U.S. tax liabilities. Substantially all of the non-U.S. loss carryforwards are not subject to any time restrictions on their future use, and $160.1 million are offset by a valuation allowance.

The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, U.S. state and non-U.S. jurisdictions. The following table provides the open tax years for which the Company could be subject to income tax examination by the tax authorities in its major jurisdictions:

Jurisdiction		Open Years
U.S. Federal		2016 — 2019
China		2009 — 2019
France		2016 — 2019
Germany		2015 — 2019

Among other regular and ongoing examinations by U.S. federal, U.S. state and non- U.S. jurisdictions globally, the Company closed the audit with German tax authorities for calendar years 2011 to 2014. German tax authorities are scheduled to begin an audit of 2015 to 2017 in 2020. There have been no significant developments with respect to the Company’s ongoing tax audits in other jurisdictions.

The Company regularly assesses the likelihood of an adverse outcome resulting from examinations to determine the adequacy of its tax reserves. As of December 31, 2019, the Company believes that it is more likely than not that the tax positions it has taken will be sustained upon the resolution of its audits resulting in no material impact on its consolidated financial position and the results of operations and cashflows. However, the final determination with respect to any tax audits, and any related litigation, could be materially different from the Company’s estimates and/or from its historical income tax provisions and accruals and could have a material effect on operating results and/or cashflows in the periods for which that determination is made. In addition, future period earnings may be adversely impacted by litigation costs, settlements, penalties, and/or interest assessments.

During the years ended December 31, 2019, 2018 and 2017, the Company recorded a change to gross unrecognized tax benefits including interest and penalties of $1.7 million, $7.6 million, and $1.7 million, respectively.

During the years ended December 31, 2019, 2018 and 2017, the Company recognized provision (benefit) for income taxes in the Consolidated Statements of Operations of $(0.3) million, $(1.0) million, and $0.3 million, respectively, for interest and penalties related to uncertain tax liabilities. As of December 31, 2019, 2018, and 2017, the Company has accrued interest and penalties of $6.4 million and $6.7 million, and $7.7 million, respectively.

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2019, 2018 and 2017 is as follows:

	2019			2018			2017
Balance at beginning of year	$	12.8		$	19.5		$	21.5
Additions based on tax positions related to the current year		0.5			0.3			0.9
Additions for tax positions of prior years		0.3			0.5			4.9
Reductions for tax positions of prior years		—			(1.7	)		(0.5	)
Reductions based on settlements with taxing authorities		(0.6	)		(0.6	)		(6.7	)
Reductions for lapse of statute		(1.5	)		(5.2	)		(0.6	)
Balance at end of year	$	11.5		$	12.8		$	19.5

Approximately $7.2 million, $7.2 million, and $13.1 million of the Company’s unrecognized tax benefits as of December 31, 2019, 2018, and 2017, respectively, would impact the effective tax rate.

During the next twelve months, the unrecognized tax benefits are not expected to significantly increase or decrease because the Company’s tax positions are sustained on audit or settled, or the applicable statute of limitations closes.

Earnings (Loss) Per Share

12 Months Ended

Dec. 31, 2019

Earnings Per Share [Abstract]

Earnings (Loss) Per Share

14. Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding of 35.5 million, 35.5 million and 35.1 million for the year ended December 31, 2019, 2018 and 2017, respectively.

Equity incentive instruments for which total employee proceeds from exercise exceed the average fair value of the same equity incentive instrument over the period have an anti-dilutive effect on earnings per share during periods with net earnings, and accordingly, the Company excludes them from the calculation. Anti-dilutive equity instruments of 1,527,645, zero and 36,300 common shares were excluded from the computation of diluted net earnings per share for the years ended December 31, 2019, 2018 and 2017, respectively. Due to the net loss during the year ended December 31, 2018, the assumed exercise of all equity incentive instruments was anti-dilutive and, therefore, not included in the diluted loss per share calculation for this period.

The following is a reconciliation of the average shares outstanding used to compute basic and diluted earnings per share:

	2019		2018		2017
Basic weighted average common shares outstanding		35,487,358		35,513,162		35,111,594
Effect of dilutive securities - stock awards		154,442		—		743,308
Diluted weighted average common shares outstanding		35,641,800		35,513,162		35,854,902

Equity

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Equity

15. Equity

Authorized capitalization consists of 75.0 million shares of $0.01 par value common stock and 3.5 million shares of $0.01 par value preferred stock. None of the preferred shares have been issued.

As of December 31, 2019, the Company has authorization to purchase up to $30.0 million of the Company’s common stock at management’s discretion. During 2019, the Company purchased $7.4 million of the Company’s common stock under this authorization.

The amount and timing of any dividends are determined by the Board of Directors at its regular meetings each year, subject to limitations within the indenture governing the Company’s 2026 Notes and the Company’s ABL Revolving Credit Facility. No cash dividends were declared or paid in the years ended December 31, 2019, 2018, and 2017.

The components of accumulated other comprehensive loss as of December 31, 2019 and 2018 are as follows:

	2019			2018
Foreign currency translation	$	(81.1	)	$	(80.1	)
Derivative instrument fair market value, net of income tax provision of $0.0 and $0.0		—			(0.3	)
Employee pension and postretirement benefit adjustments, net of income benefit of $13.7 and $13.5		(39.9	)		(36.2	)
Total accumulated other comprehensive loss	$	(121.0	)	$	(116.6	)

A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component for the years ended December 31, 2018 and 2019 are as follows:

	Gains (Losses) on Cash Flow Hedges			Pension & Postretirement			Foreign Currency Translation			Total
Balance at December 31, 2017	$	0.1		$	(45.1	)	$	(52.4	)	$	(97.4	)
Other comprehensive income (loss) before reclassifications		(5.4	)		3.5			(27.7	)		(29.6	)
Amounts reclassified from accumulated other comprehensive income		5.0			5.4			—			10.4
Net current period other comprehensive income (loss)		(0.4	)		8.9			(27.7	)		(19.2	)
Balance at December 31, 2018		(0.3	)		(36.2	)		(80.1	)		(116.6	)
Other comprehensive loss before reclassifications		(2.8	)		(5.5	)		(1.0	)		(9.3	)
Amounts reclassified from accumulated other comprehensive income		3.1			1.8			—			4.9
Net current period other comprehensive income (loss)		0.3			(3.7	)		(1.0	)		(4.4	)
Balance at December 31, 2019	$	—		$	(39.9	)	$	(81.1	)	$	(121.0	)

A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2019, 2018 and 2017 are as follows:

	Amount Reclassified from Accumulated Other Comprehensive Loss
	2019				2018			2017			Recognized Location
Gains and losses on cash flow hedges
FX Forward Contracts	$	(3.1	)	$	(5.0	)	$	(0.7	)		Cost of sales
Total before income taxes		(3.1	)		(5.0	)		(0.7	)
Income tax provision		—			—			—
Total, net of income taxes	$	(3.1	)	$	(5.0	)	$	(0.7	)
Amortization of pension and postretirement items
Actuarial losses	$	(4.6	)	$	(5.0	)	$	(5.2	)	(a)	Other expense - net
Amortization of prior service cost		2.8			2.7			1.3		(a)	Other expense - net
Pension settlement charge		—			(4.5	)		—		(a)	Other expense - net
Total before income taxes		(1.8	)		(6.8	)		(3.9	)
Income tax benefit		—			1.4			4.2
Total, net of income taxes	$	(1.8	)	$	(5.4	)	$	0.3

Total reclassifications for the period, net of income taxes	$	(4.9	)	$	(10.4	)	$	(0.4	)

(a)	These accumulated other comprehensive loss components are components of net periodic pension cost (see Note 21, “Employee Benefit Plans,” for further details).

Stock-Based Compensation

12 Months Ended

Dec. 31, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-Based Compensation

16. Stock-Based Compensation

The Company’s 2013 Omnibus Incentive Plan (the “2013 Omnibus Plan”) was approved by shareholders on May 7, 2013 and replaced the 2003 Incentive Stock and Awards Plan (the “2003 Stock Plan”). The 2013 Omnibus Plan also replaced the Company’s Short-Term Incentive Plan (the “STIP”) as of December 31, 2013. The 2003 Stock Plan and the STIP are referred to cumulatively as the “Prior Plans.” No new awards may be granted under the Prior Plans after the respective termination dates, but the Prior Plans continue to govern awards outstanding issued thereunder; outstanding awards will continue in force and effect until vested, exercised or forfeited pursuant to their terms. The 2013 Omnibus Plan provides for both short-term and long-term incentive awards for employees and non-employee directors. Stock-based awards may take the form of stock options, stock appreciation rights, restricted stock, restricted stock units, and performance share or performance unit awards. The total number of shares of the Company’s common stock available for awards under the 2013 Omnibus Plan is 7,477,395 shares. The total number of shares of the Company’s common stock still available for issuance as of December 31, 2019 is 4,992,222 shares.

The Company recognizes expense for all stock-based compensation on a straight-line basis over the vesting period of the entire award.

Total stock-based compensation expense recognized within engineering, selling and administrative expenses in the Consolidated Statements of Operations was $9.5 million, $7.5 million and $6.3 million during the years ended December 31, 2019, 2018 and 2017, respectively. In 2018 and 2017, the Company recognized $0.7 million and $0.6 million, respectively, of expense related to the modification of stock awards associated with employee severance which is included in restructuring expense in the Consolidated Statements of Operations. In 2017, the Company also recognized $0.1 million of expense related to restricted stock retention awards and modification of performance awards due to the spin-off of the former food service business in other income (expense) – net in the Consolidated Statements of Operations.

Shares are issued out of treasury stock upon exercise for stock options and vesting of restricted stock units and performance stock units.

Stock Options

Beginning in 2017, stock option grants to employees are exercisable in three annual increments over a three-year period beginning on the first anniversary of the grant date and expire 10 years subsequent to the grant date.

The Company granted stock options to employees to acquire 210,243, 187,484 and 273,800 shares of common stock during the years ended December 31, 2019, 2018 and 2017, respectively. Stock-based compensation expense is calculated by estimating the fair value of non-qualified stock options at the time of grant and is amortized over the stock options’ vesting period. The Company recognized $2.7 million, $2.4 million and $1.9 million of expense before income taxes associated with stock options during 2019, 2018 and 2017, respectively.

A summary of the Company’s stock option activity is as follows:

	Shares			Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value
Options outstanding as of December 31, 2018		956,164			21.58
Granted		210,243			18.40
Exercised		(58,404	)		6.57
Forfeited		(17,164	)		23.81
Cancelled		(24,868	)		21.18
Options outstanding as of December 31, 2019		1,065,971		$	21.75	$	0.4

Options exercisable as of December 31, 2019		623,487		$	20.96	$	0.4

The Company uses the Black-Scholes valuation model to value stock options. The Company used an average of historical stock prices of selected peers for its volatility assumption. The assumed risk-free rates were based on ten-year U.S. Treasury rates in effect at the time of grant. The expected option life represents the period of time that the options granted are expected to be outstanding and is based on historical experience.

The weighted average fair value of options granted per share during the years ended December 31, 2019, 2018 and 2017 was $8.07, $15.66 and $12.16, respectively. The fair value of each option grant was estimated at the date of grant using the following assumptions:

	2019			2018			2017
Expected life (years)		6.5			6.5			6.5
Risk-free interest rate		2.6	%		2.8	%		2.2	%
Expected volatility		39.8	%		43.7	%		45.0	%
Expected dividend yield		—	%		—	%		—	%

As of December 31, 2019, the Company has $2.3 million of unrecognized compensation expense before income tax related to stock options, which will be recognized over a weighted average period of 1.3 years.

For the years ended December 31, 2019, 2018 and 2017, the total intrinsic value of stock options exercised was $0.5 million, $1.1 million and $3.0 million, respectively.

Restricted Stock Units

The Company granted 229,044, 111,713 and 152,855 restricted stock units in 2019, 2018 and 2017, respectively, which also includes equity grants to non-employee directors of 50,673, 25,021 and 33,208 in 2019, 2018, and 2017, respectively. The Company recognized $3.4 million, $2.6 million and $3.1 million of compensation expense associated with restricted stock units during 2019, 2018 and 2017, respectively.

The restricted stock units are earned based on service over the vesting period. The equity granted to non-employee directors in 2019 and 2018 vest immediately upon the grant date. The equity granted to non-employee directors in 2017 vested on the second anniversary of the grant date, assuming continued service. Beginning in 2019, restrictions on restricted stock units granted to employees lapse in three annual increments over a three-year period beginning on the first anniversary of the grant date. Prior to 2019, restrictions on restricted stock units granted to employees lapse 100% on the third anniversary of the grant

date, assuming continued employment. The expense is based on the fair value of the Company's shares as of the grant date which, for restricted stock units, is the grant date closing stock price.

A summary of activity for restricted stock units is as follows:

	Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2018		219,917			25.37
Granted		229,044			18.39
Vested		(154,295	)		20.26
Forfeited		(4,103	)		27.34
Unvested as of December 31, 2019		290,563		$	22.55

As of December 31, 2019, the Company has $3.7 million of unrecognized compensation expense before income tax related to restricted stock units which will be recognized over a weighted average period of 1.6 years.

Performance Stock Units

The Company granted 228,037, 93,298 and 115,047 of performance stock units in 2019, 2018 and 2017, respectively. The performance stock units are earned based on service over the vesting period and on the extent to which performance goals are met over the applicable three-year performance period. The performance goals vary for performance shares each grant year. The Company recognized $3.4 million, $2.5 million and $1.3 million of compensation expense associated with performance stock units during 2019, 2018 and 2017, respectively.

The performance stock units granted in 2019 are earned based on the extent to which performance goals are met by the Company over a three-year period from January 1, 2019 to December 31, 2021. The performance goals were based fifty percent (50%) on total shareholder return relative to a peer group of companies over the three-year period and fifty percent (50%) on meeting targeted adjusted EBITDA margin at the end of the three-year period. Depending on the foregoing factors, the current number of shares awarded could range from zero to 452,890.

The performance stock units granted in 2018 are earned based on the extent to which performance goals are met by the Company over a three-year period from January 1, 2018 to December 31, 2020. The performance goals were based fifty percent (50%) on total shareholder return relative to a peer group of companies over the three-year period and fifty percent (50%) on meeting targeted adjusted EBITDA margin at the end of the three-year period. Depending on the foregoing factors, the current number of shares awarded could range from zero to 179,770.

The performance stock units granted in 2017 are earned based on the extent to which performance goals are met by the Company over a three-year period from January 1, 2017 to December 31, 2019. The performance goals were based fifty percent (50%) on total shareholder return relative to a peer group of companies over the three-year period and fifty percent (50%) on meeting targeted adjusted EBITDA margin at the end of the three-year period. Excluding potential forfeitures, the Company expects to issue 87,642 shares of common stock in 2020 related to these awards.

A summary of activity for performance stock units is as follows:

	Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2018		337,124			28.02
Granted		228,037			22.01
Vested		(74,315	)		25.73
Forfeited		(78,441	)		20.24
Unvested as of December 31, 2019		412,405		$	26.58

As of December 31, 2019, the Company has $4.3 million of unrecognized compensation expense before income tax related to performance stock units which will be recognized over a weighted average period of 2.0 years.

The expense for the adjusted EBITDA performance stock units is based on the fair value of the Company's shares as of the grant date which is the grant date closing stock price. For total shareholder return performance stock units, the Company uses the Monte Carlo valuation model to determine fair value of the grants. The Company used an average of historical stock prices of selected peers for its volatility assumption. The assumed risk-free rates were based on three-year U.S. Treasury rates in effect at the time of grant. The fair value of each total shareholder return performance stock unit was estimated at the date of grant using the following assumptions:

	2019			2018			2017
Correlation		32.5	%		29.5	%		31.6	%
Risk-free interest rate		2.5	%		2.4	%		1.5	%
Expected volatility		47.0	%		33.8	%		35.0	%
Expected dividend yield		—	%		—	%		—	%

Segments

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segments

17. Segments

The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by the CEO, who is also the Company’s Chief Operating Decision Maker (“CODM”), for making decisions about the allocation of resources and assessing performance as the source of the Company’s operating segments.

The CODM evaluates the performance of the Company’ operating segments based on net sales and operating income. Segment net sales are recognized in the geographic region the product is sold. Operating income for each segment includes net sales to third parties, cost of sales directly attributable to the segment, and operating expenses directly attributable to the segment. Manufacturing variances generated within each operating segment are maintained in each segment’s operating income. Operating income for each segment excludes other income and expense and certain expenses managed outside the operating segments. Costs excluded from segment operating income include various corporate expenses such as stock-based compensation expenses, income taxes, nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany sales between segments for management reporting purposes. The Company’s operating segments were identified as it’s reportable segments.

The following table shows information by reportable segment for the years ended December 31, 2019, 2018 and 2017:

	2019		2018			2017
Net Sales
Americas	$	969.7	$	882.7		$	693.6
EURAF		644.9		680.6			628.9
MEAP		219.5		283.5			258.8
Total	$	1,834.1	$	1,846.8		$	1,581.3
Segment Operating Income (Loss)
Americas	$	113.4	$	58.8		$	6.8
EURAF		3.8		(68.2	)		5.1
MEAP		22.6		31.5			33.1
Total	$	139.8	$	22.1		$	45.0
Depreciation
Americas	$	14.5	$	14.0		$	15.1
EURAF		15.1		15.3			15.0
MEAP		2.4		3.7			3.8
Corporate		3.0		3.1			4.2
Total	$	35.0	$	36.1		$	38.1
Capital Expenditures
Americas	$	13.2	$	9.4		$	10.6
EURAF		19.0		16.3			14.3
MEAP		2.9		3.4			3.9
Corporate		—		2.6			0.1
Total	$	35.1	$	31.7		$	28.9

A reconciliation of the Company’s segment operating income (loss) to the Consolidated Statement of Operations for the years ended December 31, 2019, 2018 and 2017 are summarized as follows:

	2019			2018			2017
Segment operating income (loss)	$	139.8		$	22.1		$	45.0
Unallocated corporate expenses		(31.3	)		(37.5	)		(33.0	)
Unallocated restructuring expense		(0.1	)		(3.9	)		(3.6	)
Total operating income (loss)	$	108.4		$	(19.3	)	$	8.4

Net sales and property, plant and equipment by geographic area as of and for the years ended December 31 are summarized below.

	Net Sales						Property, Plant and Equipment
	2019		2018		2017		2019		2018
United States	$	860.4	$	796.9	$	618.5	$	109.3	$	110.6
Europe		619.8		659.9		601.3		150.4		145.2
Other		353.9		390.0		361.5		30.2		33.1
Total	$	1,834.1	$	1,846.8	$	1,581.3	$	289.9	$	288.9

Net sales by product for the years ended December 31, 2019, 2018 and 2017 are summarized as follows:

	2019		2018		2017
Cranes	$	1,498.6	$	1,509.9	$	1,270.5
Aftermarket parts and other*		335.5		336.9		310.8
Total net sales	$	1,834.1	$	1,846.8	$	1,581.3

* Other revenue consists of revenue related to miscellaneous Crane Care services such as

training and field service work.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

18. Commitments and Contingencies

The Company is involved in various legal actions arising out of the normal course of business, which, taking into account the liabilities accrued and legal counsel’s evaluation of such actions, in the opinion of management, the ultimate resolution of all matters is not expected to have a material adverse effect on the Company’s financial condition, results of operations, or cash flows.

As of December 31, 2019, various product-related lawsuits were pending. To the extent permitted under applicable law, all of these are insured with self-insurance retention levels. The Company’s self-insurance retention levels vary by business, and have fluctuated over the last 10 years. The high-end of the Company’s self-insurance retention level is a legacy product liability insurance program inherited in the Grove acquisition for cranes manufactured in the United States for occurrences from January 2000 through October 2002. As of December 31, 2019, the largest self-insured retention level for new occurrences currently maintained by the Company is $2.0 million per occurrence and applies to product liability claims for cranes manufactured in the United States.

Product liability reserves are recorded as current liabilities in the Consolidated Balance Sheets at December 31, 2019 and 2018 and were $12.8 million and $16.3 million, respectively. These reserves were estimated using a combination of actual case reserves and actuarial methods. Based on the Company’s experience in defending product liability claims, management believes the current reserves are adequate for estimated case resolutions on aggregate self-insured claims and insured claims. Any recoveries from insurance carriers are dependent upon the legal sufficiency of claims and solvency of insurance carriers.

At December 31, 2019 and 2018, the Company had reserved $48.6 million and $38.5 million, respectively, for warranty claims included in product warranties and other non-current liabilities in the Consolidated Balance Sheets. Certain of these warranty and other related claims involve matters in dispute that ultimately are resolved by negotiation, arbitration, or litigation. See Note 19, “Guarantees,” for further information.

The Company is involved in numerous lawsuits involving asbestos-related claims in which the Company is one of numerous defendants. After taking into consideration legal counsel’s evaluation of such actions, the current political environment with respect to asbestos related claims, and the liabilities accrued with respect to such matters, in the opinion of management, ultimate resolution is not expected to have a material adverse effect on the financial condition, results of operations, or cash flows of the Company.

In 2019, the Company settled a legal matter which resulted in a net $24.4 million gain. The Company recorded this settlement by recognizing income of $15.5 million in other income (expense) and a benefit of $8.9 million in engineering, selling and administrative expenses in the Consolidated Statements of Operations for the year ended December 31, 2019.

It is reasonably possible that the estimates for warranty costs, product liability, asbestos-related claims and other various legal matters may change in the near future based upon new information that may arise or matters that are beyond the scope of the Company’s historical experience. Presently, there are no reliable methods to estimate the amount of any such potential changes.

Guarantees

12 Months Ended

Dec. 31, 2019

Guarantees [Abstract]

Guarantees

19. Guarantees

The Company periodically enters into transactions with customers that provide for buyback commitments. The Company evaluates each agreement at inception to determine if the customer has a significant economic incentive to exercise the buyback option. If it is determined that the customer has a significant economic incentive to exercise that right, the revenue is deferred and the agreement is accounted for as a lease in accordance with Topic 842. If it is determined that the customer does not have a significant economic incentive to exercise that right, then revenue is recognized when control of the product is transferred to the customer. The deferred revenue which includes buybacks and extended warranties recorded in accounts payable and accrued expenses and non-current liabilities in the Consolidated Balance Sheets as of December 31, 2019 and 2018 was $38.0 million and $34.4 million, respectively. The total amount of buyback commitments given by the Company and outstanding at December 31, 2019 and 2018 was $28.5 million and $30.9 million, respectively. These amounts are not reduced for amounts the Company would recover from repossessing and subsequent resale of the units. The buyback commitments expire at various times through 2027.

In the normal course of business, the Company provides its customers a warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects for periods ranging from 12 months to 60 months. If a product fails to comply with the Company’s warranty, the Company may be obligated, at its expense, to correct any defect by repairing or replacing such defective product. The Company provides for an estimate of costs that may be incurred under its warranty at the time product revenue is recognized. These costs primarily include labor and materials, as necessary, associated with repair or replacement. The primary factors that affect the Company’s warranty liability include the number of units shipped and historical and anticipated warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liability and adjusts the amounts as necessary. Below is a table summarizing the warranty activity for the years ended December 31, 2019, 2018 and 2017:

	2019			2018			2017
Balance at beginning of period	$	47.8		$	44.5		$	44.1
Accruals for warranties issued during the period		47.3			38.0			34.5
Settlements made (in cash or in kind) during the period		(34.2	)		(33.8	)		(36.9	)
Currency translation		(0.3	)		(0.9	)		2.8
Balance at end of period	$	60.6		$	47.8		$	44.5

Included in the balance at end of period as of December 31, 2019 and 2018 is $13.4 million and $8.7 million, respectively, of long-term warranty which is recorded in other non-current liabilities in the Consolidated Balance Sheets.

Restructuring

12 Months Ended

Dec. 31, 2019

Restructuring And Related Activities [Abstract]

Restructuring

20. Restructuring

During the years ended December 31, 2019, 2018 and 2017, the Company incurred $9.8 million, $12.9 million and $27.2 million of restructuring expense, respectively. The costs for 2019 related primarily to severance costs for headcount reductions in Europe, North America and India. The costs for 2018 related primarily to severance costs for the departure of an executive officer, costs associated with training of skilled labor as a result of the transfer of crawler production to Shady Grove, PA and costs associated with headcount reductions in Europe. The costs for 2017 related primarily to the closure of manufacturing operations in Manitowoc, WI and Passo Fundo, Brazil and severance costs associated with headcount reductions in North America. The restructuring expense for the years ended December 31, 2019, 2018 and 2017 included zero, $2.0 million and $2.8 million, respectively, of expense related to executive severance.

The following is a summary of the Company's restructuring activities for the years ended December 31, 2019, 2018 and 2017:

	2019			2018			2017
Balance at beginning of period	$	3.3		$	5.6		$	8.2
Restructuring expenses		9.8			12.9			27.2
Use of reserve		(10.9	)		(15.1	)		(28.8	)
Reserve reclassification		(0.2	)		—			(1.2	)
Currency translation		—			(0.1	)		0.2
Balance at end of period	$	2.0		$	3.3		$	5.6

Employee Benefit Plans

12 Months Ended

Dec. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Employee Benefit Plans

21. Employee Benefit Plans

The Company provides defined benefit pension plans, defined contribution plans and/or other postretirement benefit plans to employees in many of the Company’s locations throughout the world. The Company’s defined benefit plans provide a benefit based on years of service and/or the employee’s average earnings near retirement. The Company’s defined contribution plans allow employees to contribute a portion of their salary to help save for retirement, and in most cases, the Company provides a matching contribution. The benefit obligation related to the Company’s non-U.S. defined benefit pension plans are for employees located primarily in Europe. For postretirement medical and other benefit plans, all of the Company’s benefit obligation is for employees located in the United States.

Defined contribution plans

The Company maintains two defined contribution retirement plans for its employees in the United States: (1) The Manitowoc Company, Inc. 401(k) Retirement Plan (the “Manitowoc 401(k) Retirement Plan”) and (2) The Manitowoc Company, Inc. Deferred Compensation Plan (the “Manitowoc Deferred Compensation Plan”). During 2019, the Manitowoc Retirement Savings Plan merged with The Manitowoc 401(k) Retirement Plan, with The Manitowoc 401(k) Retirement Plan being the surviving plan. Each plan results in individual participant balances that reflect a combination of amounts contributed by the Company or deferred by the participant, amounts invested at the direction of either the Company or the participant, and the continuing reinvestment of returns until the accounts are distributed.

The Company also has various other non-U.S. defined contribution plans that allow eligible employees to contribute a portion of their salary to the plans. In most cases, the Company provides a matching contribution to the funds. Company contributions to the plans are generally based upon formulas contained in the plans. Total costs incurred under the Non-U.S. defined contribution plans, and reported within the Consolidated Statement of Operations, were $1.2 million, $1.3 million and $1.5 million for the years ended December 31, 2019, 2018 and 2017, respectively.

Manitowoc 401(k) Retirement Plan

The Manitowoc 401(k) Retirement Plan is a tax-qualified retirement plan that is available to substantially all U.S. employees of Manitowoc, its subsidiaries and related entities.

The Manitowoc 401(k) Retirement Plan allows employees to make both pre- and Roth, after-tax elective deferrals, subject to certain limitations under the Internal Revenue Code of 1986, as amended (the “Tax Code”). The Company also has the right to make the following additional contributions: (1) a safe harbor matching contribution and (2) an additional contribution, which may or may not be made, at the full discretion of the Company and for which the value will be fully determined by the Company based on company performance. Each participant in the Manitowoc 401(k) Retirement Plan is allowed to direct the investment of that participant’s account among a diverse mix of investment funds, including a Company stock alternative. To the extent that any funds are invested in the Company’s stock, that portion of the Manitowoc 401(k) Retirement Plan is an employee stock ownership plan, as defined under the Tax Code (an “ESOP”).

The terms governing the retirement benefits under the Manitowoc 401(k) Retirement Plan are the same for the Company’s executive officers as they are for other eligible employees in the U.S.

Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, were $6.3 million, $6.2 million and $4.9 million for the years ended December 31, 2019, 2018 and 2017, respectively.

Manitowoc Deferred Compensation Plan

The Manitowoc Deferred Compensation Plan is a non-tax-qualified supplemental deferred compensation plan for highly compensated and key management employees and for non-employee directors of the Company. The Company maintains the Manitowoc Deferred Compensation Plan to allow eligible individuals to save for retirement in a tax-efficient manner despite Tax Code restrictions that would otherwise impair their ability to do so under the Manitowoc 401(k) Retirement Plan. The Manitowoc Deferred Compensation Plan also assists the Company in retaining those key employees and directors.

The Manitowoc Deferred Compensation Plan accounts are credited with: (1) elective deferrals made at the request of the individual participant; and/or (2) an additional contribution from the Company for each individual participant, which may or may not be made, at the full discretion of the Company based on the Company’s performance. Although unfunded within the meaning of the Tax Code, the Manitowoc Deferred Compensation Plan utilizes a rabbi trust to hold assets intended to satisfy the Company’s corresponding future benefit obligations. Each participant in the Manitowoc Deferred Compensation Plan is

credited with earnings based upon individual elections from amongst a diverse mix of investment funds that are intended to reflect investment funds similar to those offered under the Manitowoc 401(k) Retirement Plan, including the Company’s stock. Participants do not receive preferential or above-market rates of return under the Manitowoc Deferred Compensation Plan.

The Company has two separate investment programs: Program A and B, which participants are able to direct deferrals and Company contributions, which restrict the Company’s use and access to the funds, but which are also subject to the claims of the Company’s general creditors in rabbi trusts. Program A invests solely in the Company’s stock; dividends paid on the Company’s stock are automatically reinvested; and all distributions must be made in Company stock. Program B offers a variety of investment options but does not include Company stock as an investment option. All distributions from Program B must be made in cash. Participants cannot transfer assets between programs.

Program A is accounted for as a plan that does not permit diversification. As a result, the Company stock held by Program A is classified in equity in a manner similar to accounting for treasury stock. The deferred compensation obligation is classified as an equity instrument. Changes in the fair value of the Company’s stock and the compensation obligation are not recognized. The asset and obligation for Program A were $0.5 million and $0.2 million at December 31, 2019 and 2018, respectively.

Program B is accounted for as a plan that permits diversification. As a result, the assets held by Program B are classified as an asset in the Consolidated Balance Sheets and changes in the fair value of the assets are recognized in earnings. The deferred compensation obligation is classified as a liability in the Consolidated Balance Sheets and adjusted, with a charge or credit to compensation cost, to reflect changes in the fair value of the obligation. The assets, which are included in other non-current assets, and obligations, which are included in other non-current liabilities, were $8.4 million and $8.7 million at December 31, 2019 and 2018, respectively. Total costs incurred under this plan, and reported within the Consolidated Statement of Operations, for the years ended December 31, 2019, 2018 and 2017 were $0.5 million, $0.3 million and zero, respectively.

Pension, Postretirement Medical and Other Benefit Plans

The Company provides certain pension, postretirement medical and other benefits (death benefits) for eligible retirees and their dependents. The pension benefits are funded, the postretirement medical benefits are not funded but are paid as incurred, and the death benefits are fully insured. Eligibility for coverage is based on meeting certain years of service and retirement qualifications. The healthcare benefits may be subject to deductibles, co-payment provisions, and other limitations. The Company has reserved the right to modify these benefits. As of December 31, 2010, all of the remaining U.S. defined benefit pension plans were merged into a single plan: the Manitowoc U.S. Pension Plan (“U.S. Pension Plans”). All merged plans had benefit accruals frozen prior to the merger of the plans.

In September 2018, the U.S. Pension Plans entered into and closed on a definitive agreement with an insurance company to purchase a group annuity contract to transfer $18.6 million of the Company’s outstanding pension benefit obligations related to certain U.S. retirees and beneficiaries. As a result of the transaction, the insurance company is required to pay and administer the retirement benefits owed to the 622 retirees and beneficiaries of the U.S. Pension Plans starting on December 1, 2018. There was no change to their monthly benefit payment amounts. In connection with this transaction, the Company recognized a non-cash pension settlement charge of $4.5 million in other income (expense) primarily related to the accelerated recognition of actuarial losses included in accumulated other comprehensive loss for the U.S. Pension Plans.

In addition to the U.S. Pension Plans, the Company also maintains defined benefit pension plans for various Non-US subsidiaries which are sponsored directly by the Company or its subsidiaries and offered only to employees or retirees of those subsidiaries (“Non-U.S. Pension Plans”).

Effective July 1, 2017, The Manitowoc Company, Inc. Post-65 Retiree Health Plan (the “Plan”) was amended. Eligible retirees and their spouses were provided access to a Retiree Health Exchange where they may purchase Medicare Supplement Plans, including Medicare Advantage and Medigap plan prescription drug coverage. The enrollment and payment for this coverage is facilitated by a third-party, and these plans have no affiliation with the Company. To assist retirees with premium and out-of-pocket expenses, the Company funds a Health Reimbursement Account (“HRA”) for each enrolled retiree. The value of the HRA is based on the plan type and premium cost for each specific retiree before the Plan was amended.

The components of periodic benefit costs for the years ended December 31, 2019, 2018 and 2017 are as follows:

	US Pension Plans									Non-US Pension Plans									Postretirement Medical and Other
	2019			2018			2017			2019			2018			2017			2019			2018			2017
Service cost - benefits earned during the year	$	—		$	—		$	—		$	1.8		$	1.8		$	1.9		$	0.2		$	0.2		$	0.3
Interest cost of projected benefit obligation		5.1			5.2			5.3			2.2			2.1			2.1			0.8			0.8			1.0
Expected return on assets		(4.3	)		(5.7	)		(4.9	)		(1.4	)		(1.4	)		(1.5	)		—			—			—
Amortization of prior service cost		—			—			—			0.1			0.1			0.1			(2.8	)		(2.8	)		(1.4	)
Amortization of actuarial net loss (gain)		3.3			2.9			3.2			1.3			1.3			1.6			—			0.8			0.4
Pension settlement charge		—			4.5			—			—			—			—			—			—			—
Net periodic benefit cost	$	4.1		$	6.9		$	3.6		$	4.0		$	3.9		$	4.2		$	(1.8	)	$	(1.0	)	$	0.3
Weighted average assumptions:
Discount rate		4.3	%		3.8	%		4.2	%		2.5	%		2.2	%		2.1	%		4.1	%		3.3	%		3.8	%
Expected return on plan assets		5.2	%		5.3	%		4.7	%		3.5	%		2.7	%		3.4	%	N/A			N/A			N/A
Rate of compensation increase	N/A			N/A			N/A				3.6	%		3.5	%		2.6	%	N/A			N/A			N/A

The prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10% of the greater of the benefit obligation and the market-related value of assets are amortized over the average remaining service period of active participants.

To develop the expected long-term rate of return on assets assumptions, the Company considered the historical returns and future expectations for returns in each asset class, as well as targeted asset allocation percentages within the pension portfolio.

The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2019 and 2018:

	US Pension Plans						Non-US Pension Plans						Postretirement Medical and Other
	2019			2018			2019			2018			2019			2018
Change in Benefit Obligation
Benefit obligation, beginning of year	$	130.5		$	162.3		$	81.9		$	89.5		$	20.7		$	28.9
Service cost		—			—			1.8			1.8			0.2			0.2
Interest cost		5.1			5.2			2.2			2.1			0.8			0.8
Participant contributions		—			—			—			—			0.4			0.7
Plan amendments		—			—			—			—			—			—
Actuarial (gain) loss		13.8			(9.2	)		8.3			(3.0	)		(1.5	)		(7.2	)
Currency translation adjustment		—			—			1.1			(4.6	)		—			—
Pension settlement		—			(18.9	)		—			—			—			—
Benefits paid		(7.1	)		(8.8	)		(4.7	)		(3.9	)		(2.2	)		(2.7	)
Benefit obligation, end of year	$	142.3		$	130.5		$	90.6		$	81.9		$	18.4		$	20.7
Change in Plan Assets
Fair value of plan assets, beginning of year	$	84.9		$	116.2		$	40.1		$	45.1		$	—		$	—
Actual return on plan assets		16.8			(8.9	)		4.2			(1.4	)		—			—
Employer contributions		5.0			5.3			4.0			2.8			1.8			2.0
Participant contributions		—			—			—			—			0.4			0.7
Currency translation adjustment		—			—			1.6			(2.5	)		—			—
Pension settlement		—			(18.9	)		—			—			—			—
Benefits paid		(7.1	)		(8.8	)		(4.7	)		(3.9	)		(2.2	)		(2.7	)
Fair value of plan assets, end of year		99.6			84.9			45.2			40.1			—			—
Funded status	$	(42.7	)	$	(45.6	)	$	(45.4	)	$	(41.8	)	$	(18.4	)	$	(20.7	)
Amounts recognized in the Consolidated Balance sheet at December 31
Pension asset	$	—		$	—		$	—		$	—		$	—		$	—
Pension obligation		(42.7	)		(45.6	)		(45.4	)		(41.8	)		—			—
Postretirement medical and other benefit obligations		—			—			—			—			(18.4	)		(20.7	)
Net amount recognized	$	(42.7	)	$	(45.6	)	$	(45.4	)	$	(41.8	)	$	(18.4	)	$	(20.7	)
Weighted-Average Assumptions
Discount rate		3.3	%		4.3	%		1.5	%		2.2	%		2.9	%		4.1	%
Expected return on plan assets		5.2	%		5.3	%		3.5	%		2.7	%	N/A			N/A
Rate of compensation increase	N/A			N/A				3.6	%		3.5	%	N/A			N/A

The Company prepares its discount rates with advice from an independent third party. The Company uses different discount rates for each plan depending on the plan jurisdiction, the demographics of participants and the expected timing of benefit payments. For the qualified U.S. pension plan and postretirement medical plans, the Company uses a discount rate calculated based on an appropriate mix of high-quality corporate bonds. For the non-U.S. pension and postretirement plans, the Company consistently uses the relevant country specific benchmark indices for determining the various discount rates.

Amounts recognized in accumulated other comprehensive loss as of December 31, 2019 and 2018, are summarized as follows:

	Pensions						Postretirement Medical and Other
	2019			2018			2019		2018
Net actuarial gain (loss)	$	(61.9	)	$	(59.3	)	$	1.9	$	0.4
Prior service credit (cost)		(0.5	)		(0.5	)		6.9		9.7
Total amount recognized	$	(62.4	)	$	(59.8	)	$	8.8	$	10.1

For measurement purposes, a 5.72% annual rate of increase in the per capita cost of covered health care benefits was assumed for 2019. The rate was assumed to decrease gradually to 4.50% in 2038 and remain at that level thereafter. Assumed health care cost trend rates have a significant effect on the amounts reported for the health care plans.

The following table summarizes the sensitivity of our December 31, 2019 retirement obligations and 2020 retirement benefit costs of our plans to changes in the key assumptions used to determine those results:

Change in assumption:	Estimated increase (decrease) in 2020 pension cost			Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019			Estimated decrease in 2020 Other Postretirement Benefit costs			Estimated increase (decrease) in Other Postretirement Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	$	(0.8	)	$	(14.3	)	N/A			$	(0.6	)
0.50% decrease in discount rate		0.9			15.7			(0.1	)		0.6
0.50% increase in long-term return on assets		(0.7	)	N/A			N/A			N/A
0.50% decrease in long-term return on assets		0.7		N/A			N/A			N/A
1% increase in medical trend rates	N/A			N/A			N/A				0.7
1% decrease in medical trend rates	N/A			N/A				(0.1	)		(0.6	)

It is reasonably possible that the estimate for future retirement and medical costs may change in the near future due to changes in interest rates. Presently, there is no reliable means to estimate the amount of any such potential changes.

The weighted-average asset allocations of the U.S. pension plans as of December 31, 2019 and 2018, by asset category are as follows:

	2019			2018
Equity		50.4	%		47.8	%
Fixed income		48.9	%		51.4	%
Other		0.7	%		0.8	%
Total		100.0	%		100.0	%

The weighted-average asset allocations of the Non-U.S. pension plans as of December 31, 2019 and 2018, by asset category are as follows:

	2019			2018
Equity		0.0	%		36.1	%
Fixed income		31.9	%		31.6	%
Other*		68.1	%		32.3	%
Total		100.0	%		100.0	%
*Includes diversified investments that have equity and fixed income holdings.

The Board of Directors has established the Retirement Plan Committee (the “Committee”) to manage the operations and administration of all benefit plans and related trusts. On a quarterly basis, the Committee reviews progress toward achieving the pension plans’ and individual investment managers’ performance objectives.

Investment Strategy The overall objective of the Company's pension assets is to earn a rate of return over time to satisfy the benefit obligations of the pension plans and to maintain sufficient liquidity to pay benefits and address other cash requirements of the pension funds. Specific investment objectives for the Company’s long-term investment strategy include reducing the volatility of pension assets relative to pension liabilities, achieving a competitive, total investment return, achieving diversification between and within asset classes and managing other risks. Investment objectives for each asset class are determined based on specific risks and investment opportunities identified.

The Company reviews its long-term, strategic asset allocations annually. The Company uses various analytics to determine the optimal asset mix and considers plan liability characteristics, liquidity characteristics, funding requirements, expected rates of return and the distribution of returns. The Company identifies investment benchmarks for the asset classes in the strategic asset allocation that are market-based.

Actual allocations to each asset class vary from target allocations due to periodic investment strategy changes, market value fluctuations, the length of time it takes to fully implement investment allocation positions and the timing of benefit payments and contributions. The asset allocation is monitored and rebalanced monthly.

The actual and target allocations for the pension assets as of December 31, 2019, by asset class, are as follows:

	Target Allocations						Weighted Average Asset Allocations
	U.S. Plans			Non-U.S. Plans			U.S. Plans			Non-U.S. Plans
Equity Securities		50	%		—	%		50.4	%		0.0	%
Debt Securities		50	%	40%				48.9	%		31.9	%
Other		—	%	60%				0.7	%		68.1	%

Risk Management In managing the plan assets, the Company reviews and manages risk associated with funded status risk, interest rate risk, market risk, counterparty risk, liquidity risk and operational risk. Liability management and asset class diversification are central to the Company’s risk management approach and are integral to the overall investment strategy. Further, asset classes are constructed to achieve diversification by investment strategy, by investment manager, by industry or sector and by holding. Investment manager guidelines for publicly traded assets are specified and are monitored regularly.

Fair Value Measurements The following table presents the Company’s plan assets using the fair value hierarchy as of December 31, 2019 and 2018. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant other observable inputs, and Level 3 includes fair values estimated using significant non-observable inputs.

	December 31, 2019
Assets	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)		Net Asset Value ("NAV")		Total
Cash and cash equivalents	$	2.4	$	—	$	—	$	—	$	2.4
Insurance group annuity contracts		—		—		12.6		—		12.6
Common/collective trust funds — Corporate and other non-government debt		—		—		—		22.9		22.9
Common/collective trust funds — Government, corporate and other non-government debt		—		—		—		40.2		40.2
Common/collective trust funds — Corporate equity		—		—		—		50.3		50.3
Common/collective trust funds — Customized strategy		—		—		—		16.4		16.4
Total	$	2.4	$	—	$	12.6	$	129.8	$	144.8

	December 31, 2018
Assets	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)		Net Asset Value ("NAV")		Total
Cash and cash equivalents	$	1.7	$	—	$	—	$	—	$	1.7
Insurance group annuity contracts		—		—		12.0		—		12.0
Common/collective trust funds — Government, corporate and other non-government debt		—		—		—		56.3		56.3
Common/collective trust funds — Corporate equity		—		—		—		55.0		55.0
Total	$	1.7	$	—	$	12.0	$	111.3	$	125.0

Cash and cash equivalents, which are used to pay benefits, are primarily held in registered money market funds which are valued using a market approach based on the quoted market prices of identical instruments. Other cash and cash equivalents are valued daily by the fund using a market approach with inputs that include quoted market prices for similar instruments.

Insurance group annuity contracts are valued at the present value of the future benefit payments owed by the insurance Company to the Non-U.S. Pension Plans’ participants.

Common/collective funds are typically common or collective trusts valued at their net asset values that are calculated by the investment manager or sponsor of the fund and have daily or monthly liquidity. The Company believes that NAV is representative of fair value at the reporting date, as there are no significant restrictions on redemption on these investments or other reasons to indicate that the investment would be redeemed at an amount different than NAV.

The valuation methodologies described above may generate a fair value calculation that may not be indicative of net realizable value or future fair values. While the Company believes the valuation methodologies used are appropriate, the use of different methodologies or assumptions in calculating fair value could result in different amounts.

A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows:

	Insurance Contracts Year Ended December 31,
	2019			2018
Beginning Balance	$	12.0		$	14.4
Actual return on assets		1.1			(0.3	)
Benefit payments		(1.0	)		(1.3	)
Foreign currency impact		0.5			(0.8	)
Ending Balance	$	12.6		$	12.0

The expected 2020 contributions for the U.S. pension plans are as follows: the minimum contribution for 2020 is $8.0 million; and no planned discretionary or non-cash contributions. The expected 2020 contributions for the non-U.S. pension plans are as follows: the minimum contribution for 2020 is $3.1 million; and no planned discretionary or non-cash contributions. Expected Company paid claims for the postretirement medical and life insurance plans are $2.1 million for 2020. Projected future benefit payments from the plans as of December 31, 2019 are estimated as follows:

	U.S Pension Plans		Non-U.S. Pension Plans		Postretirement Medical and Other
2020	$	8.5	$	3.1	$	2.1
2021		8.6		2.9		2.0
2022		8.7		3.1		1.9
2023		8.8		3.5		1.8
2024		8.8		3.6		1.7
Thereafter		43.0		21.1		6.6
Total	$	86.4	$	37.3	$	16.1

The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2019 and 2018 is as follows:

	U.S Pension Plans				Non U.S. Pension Plans
	2019		2018		2019		2018
Projected benefit obligation	$	142.3	$	130.5	$	90.5	$	81.9
Accumulated benefit obligation		142.3		130.5		86.4		78.1
Fair value of plan assets		99.6		84.9		45.2		40.1

The measurement date for all plans is December 31, 2019.

In 2019, the Company made final benefit payments of $2.5 million from The Manitowoc Company, Inc. Supplemental Executive Retirement Plan, which terminated the plan. Expenses related to this plan were $0.2 million and $1.2 million in 2018 and 2017, respectively.

Leases

12 Months Ended

Dec. 31, 2019

Leases [Abstract]

Leases

22. Leases

As of January 1, 2019, the Company adopted Topic 842 and elected to use the modified prospective approach, which does not require a retrospective restatement of prior years. The adoption of Topic 842 resulted in no cumulative catch-up to retained earnings. As part of the adoption, the Company applied the package of practical expedients which does not require the Company to reassess the lease classification for any expired or existing leases upon adoption of Topic 842.

The Company has operating leases for offices, warehouses, land for storage of cranes, vehicles, information technology equipment, and manufacturing equipment. The remaining lease terms are up to 24 years, some of which include options to extend the lease term for up to 10 years, and some which include options to terminate the lease within 1 year. Certain leases include one or more options to renew; the exercise of lease renewal options is at the Company’s discretion. The Company includes renewal option periods in the lease term when it is determined that the options are reasonably certain to be exercised. The Company’s financing leases have an immaterial impact on the consolidated financial statements.

The components of lease expense for the year ended December 31, 2019 are summarized as follows:

	2019
Operating lease cost	$	14.4
Variable lease cost*		1.4
Total lease cost	$	15.8
*Includes short-term leases, which are immaterial.

Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2019 are summarized as follows:


Operating lease right-of-use assets	$	47.6

Other liabilities	$	10.4
Operating lease liabilities		37.6
Total operating lease liabilities	$	48.0

Cash paid for operating leases included in operating cash flows was $27.4 million for the year ended December 31, 2019.

As of December 31, 2019, the Company’s operating leases have a weighted-average remaining lease term of 7.3 years and a weighted average discount rate of 4.66%. Topic 842 requires a lessee to discount its unpaid lease obligations using the interest rate implicit in the lease, or if not readily determinable, the incremental borrowing rate. Generally, the Company uses its incremental borrowing rate as the implicit rate cannot be determined. The Company’s incremental borrowing rate for a lease is the rate of interest the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms in the same location.

Maturities of operating lease liabilities as of December 31, 2019 are summarized as follows:

Year
2020	$	12.1
2021		10.2
2022		8.3
2023		6.0
2024		4.5
Thereafter		16.5
Total lease payments		57.6
Less: imputed interest		(9.6	)
Present value of lease liabilities	$	48.0

Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Data (Unaudited)

23. Quarterly Financial Data (Unaudited)

The following tables present select quarterly financial data for 2019 and 2018:

Historical	2019									2018
	First			Second		Third		Fourth		First			Second			Third			Fourth
Statements of operations:
Net sales	$	418.0		$	504.7	$	448.0	$	463.4	$	386.1		$	495.3		$	450.1		$	515.3
Cost of sales		337.8			409.5		359.6		383.1		317.7			404.8			370.1			426.1
Gross profit		80.2			95.2		88.4		80.3		68.4			90.5			80.0			89.2
Operating income (loss)		16.2			41.9		32.5		17.8		1.7			24.1			16.9			(62.0	)
Income (loss) from continuing operations before income taxes		(23.4	)		49.9		21.2		11.3		(6.1	)		8.7			0.8			(75.1	)
Provision (benefit) for income taxes		3.3			3.9		3.1		2.1		3.9			(1.2	)		(10.7	)		3.2
Net income (loss) from continuing operations		(26.7	)		46.0		18.1		9.2		(10.0	)		9.9			11.5			(78.3	)
Loss from discontinued operations, net of income taxes		—			—		—		—		—			(0.2	)		—			—
Net income (loss)	$	(26.7	)	$	46.0	$	18.1	$	9.2	$	(10.0	)	$	9.7		$	11.5		$	(78.3	)
Basic (loss) income per share:
Net income (loss) income from continuing operations	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.28		$	0.32		$	(2.20	)
Loss from discontinued operations		—			—		—		—		—			(0.01	)		—			—
Net income (loss) per share	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Diluted (loss) income per share:
Net income (loss) from continuing operations	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Loss from discontinued operations		—			—		—		—		—			—			—			—
Net income (loss) per share	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Dividends per common share	$	—		$	—	$	—	$	—	$	—		$	—		$	—		$	—

Schedule II: Valuation and Qualifying Accounts

12 Months Ended

Dec. 31, 2019

Valuation And Qualifying Accounts [Abstract]

Schedule II: Valuation and Qualifying Accounts

(c)

Financial Statement Schedule

THE MANITOWOC COMPANY, INC

AND SUBSIDIARIES

Schedule II: Valuation and Qualifying Accounts

For the Years Ended December 31, 2019, 2018 and 2017

(dollars in millions)

	Balance at Beginning of Year		Charge to Costs and Expenses		Utilization of Reserve			Other, Primarily Impact of Foreign Exchange Rates			Balance at end of Year
Year End December 31, 2017
Allowance for doubtful accounts	$	11.1	$	1.7	$	(2.7	)	$	0.8		$	10.9
Deferred tax valuation allowance	$	269.6	$	15.2	$	(128.7	)	$	6.2		$	162.3
Year End December 31, 2018
Allowance for doubtful accounts	$	10.9	$	2.6	$	(2.4	)	$	(0.8	)	$	10.3
Deferred tax valuation allowance	$	162.3	$	14.4	$	(13.1	)	$	(10.5	)	$	153.1
Year End December 31, 2019
Allowance for doubtful accounts	$	10.3	$	1.4	$	(3.9	)	$	0.2		$	7.9
Deferred tax valuation allowance	$	153.1	$	11.7	$	(7.2	)	$	(0.5	)	$	157.1

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Cash and Cash Equivalents

Cash and Cash Equivalents The Company considers all cash and short-term investments purchased with an original maturity of three months or less as cash and cash equivalents.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts Accounts receivable are reduced by an allowance for amounts that may become uncollectible in the future. Our estimate for the allowance for doubtful accounts related to trade receivables includes evaluation of specific accounts where we have information that the customer may have an inability to meet its financial obligations together with a general provision for unknown but existing doubtful accounts based on historical experience, which are subject to change if experience improves or deteriorates.

Inventories

Inventories Inventories are valued at the lower of cost or net realizable value. Finished goods and work-in-process inventories include material, labor and manufacturing overhead costs. The Company determines inventory value using the first-in, first-out method.

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets The Company accounts for goodwill and other intangible assets under the guidance of Accounting Standards Codification (“ASC”) Topic 350-10, “Intangibles — Goodwill and Other.” Under ASC Topic 350-10, goodwill is not amortized; instead, the Company performs an annual impairment review. The date for the annual impairment review is October 31, or more frequently if events or changes in circumstances indicate that the assets might be impaired. To test goodwill, the Company estimates the fair values of its reporting units using the income approach based on the present value of expected future cash flows, subject to a comparison for reasonableness to its market capitalization at the date of valuation. If the carrying amount exceeds the fair value, an impairment loss is recognized in an amount equal to that excess, not to exceed the carrying amount of the goodwill. In addition, goodwill of a reporting unit is tested for impairment between annual tests if an event occurs or circumstances change that would more-likely-than-not reduce the fair value of a reporting unit below its carrying value.

The Company’s other intangible assets with indefinite lives, including trademarks and tradenames and distribution networks, are not amortized but are tested for impairment annually, or more frequently, as events dictate. For other indefinite lived intangible assets, the impairment test consists of a comparison of the fair value of the intangible assets to their carrying amount. See Note 9, “Goodwill and Other Intangible Assets,” for further details on our impairment assessments. The Company’s intangible assets subject to amortization are tested for impairment whenever events or changes in circumstances indicate that their carrying values may not be recoverable.

The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives:

		Useful lives
Patents		20 years
Customer relationships		20 years

Property, Plant and Equipment

Property, Plant and Equipment Property, plant and equipment are stated at cost. Expenditures for maintenance, repairs and minor renewals are charged against earnings as incurred. Expenditures for major renewals and improvements that substantially extend the capacity or useful life of an asset are capitalized and are then depreciated. The cost and accumulated depreciation for property, plant and equipment sold, retired or otherwise disposed of are relieved from the accounts, and resulting gains or losses are reflected in earnings. Property, plant and equipment are depreciated over the estimated useful lives of the assets using the straight-line depreciation method for financial reporting and accelerated depreciation methods for income tax purposes.

Property, plant and equipment are depreciated over the following estimated useful lives:

		Years
Building and improvements		2 - 43
Machinery, equipment and tooling		3 - 18
Furniture and fixtures		3 - 10
Computer hardware and software		2 - 10
Rental cranes		5 - 15

Property, plant and equipment also includes cranes accounted for as operating leases. Equipment accounted for as operating leases includes rental cranes leased directly to the customer and cranes for which the Company has assisted in the financing arrangement, whereby the Company has made a buyback commitment in which the customer has a significant economic incentive of exercising. Equipment that is leased directly to the customer is accounted for as an operating lease with the related assets capitalized and depreciated over their estimated economic life. Equipment involved in a financing arrangement is depreciated over the life of the underlying arrangement to the buyback amount at the end of the lease period. The amount of buyback and rental equipment included in property, plant and equipment amounted to $51.2 million and $49.4 million, net of accumulated depreciation, at December 31, 2019 and 2018, respectively.

The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the assets’ carrying amount may not be recoverable. The Company conducts its impairment analyses in accordance with ASC Topic 360-10-5 “Property, Plant and Equipment” (“Topic 360”). Topic 360 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and to evaluate the asset group against the sum of the undiscounted future cash flows. If an impairment is determined to exist, any related impairment loss is calculated based upon comparison of the expected undiscounted future cash flows to the net book value of the assets.

Warranties

Warranties Estimated standard manufacturing warranty costs are recorded in cost of sales at the time of sale of the warranted products based on historical warranty experience for the related product or estimates of projected costs due to specific warranty issues on new products. These estimates are reviewed periodically and are adjusted based on changes in facts, circumstances or actual experience. When a customer purchases an extended warranty, revenue associated with the extended warranty is deferred and recognized over the life of the extended warranty period. Costs related to the extended warranty are expensed as incurred.

Product Liabilities

Product Liabilities The Company records product liability reserves for its self-insured portion of any pending or threatened product liability actions when losses are probable and reasonably estimable. The reserve is based upon two estimates. First, the Company tracks the population of all outstanding pending and threatened product liability cases to determine an appropriate case reserve for each based upon the Company’s best judgment with the advice of legal counsel. These estimates are continually evaluated and adjusted based upon changes to facts and circumstances surrounding the case. Second, the Company determines the amount of additional reserve required to cover incurred, but not reported, product liability obligations and to account for possible adverse development of the established case reserves utilizing actuarially developed estimates.

Derivative Financial Instruments and Hedging Activities

Derivative Financial Instruments and Hedging Activities The Company has policies and procedures that place all financial instruments under the direction of corporate treasury and restrict all derivative transactions to those intended for hedging purposes. The use of financial instruments for trading purposes is strictly prohibited. The Company uses financial instruments

to manage the market risk from changes in foreign exchange rates, commodities and interest rates. The Company follows the guidance in accordance with ASC No. 815 “Derivatives and Hedging” (“Topic 815”). The fair values of all outstanding derivatives are recorded in the Consolidated Balance Sheets. The change in a derivative’s fair value is recorded each period in current earnings or accumulated other comprehensive income (loss) (“AOCI”) depending on whether the derivative is designated and qualifies as a cash flow hedge.

The Company selectively hedges anticipated transactions that are subject to foreign exchange exposure, commodity price exposure or variable interest rate exposure, primarily using foreign currency exchange contracts (“FX Forward Contracts”), commodity contracts and interest rate contracts, respectively. These instruments are designated as cash flow hedges in accordance with Topic 815 and are recorded in the Consolidated Balance Sheets at fair value. The effective portion of the contracts’ gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions, typically sales and costs related to sales and interest expense, occur and affect earnings. These contracts are highly effective in hedging the variability in future cash attributable to changes in currency exchange rates, commodity prices or interest rates.

The amount reported as derivative instrument fair market value adjustment in the AOCI account within the Consolidated Statements of Comprehensive Income (Loss) represents the net gain (loss) on foreign currency exchange contracts designated as cash flow hedges, net of income taxes.

Stock-Based Compensation

Stock-Based Compensation The Company recognizes expense for all stock-based compensation with graded vesting on a straight-line basis over the vesting period of the entire award. Stock-based compensation plans are described more fully in Note 16, “Stock-Based Compensation.”

Research and Development

Research and Development Research and development costs are charged to expense as incurred and amounted to $31.1 million, $35.2 million and $37.9 million for the years ended December 31, 2019, 2018 and 2017, respectively. Research and development costs include salaries, materials, contractor fees and other administrative costs.

Income Taxes

Income Taxes The Company utilizes the liability method to recognize deferred tax assets and liabilities for the expected future income tax consequences of events that have been recognized in the Company’s financial statements. Under this method, deferred tax assets and liabilities are determined based on the temporary difference between financial statement carrying amounts and the tax basis of assets and liabilities using enacted tax rates in effect in the years in which the temporary differences are expected to reverse. Valuation allowances are provided for deferred tax assets where it is considered more likely than not that the Company will not realize the benefit of such assets. The Company evaluates its uncertain tax positions as new information becomes available. Tax benefits are recognized to the extent a position is more likely than not to be sustained upon examination by the taxing authority.

Earnings Per Share

Earnings Per Share Basic earnings per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each year or period. The calculation of diluted earnings (loss) per share reflects the effect of all dilutive potential shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive. The Company uses the treasury stock method to calculate the effect of outstanding stock-based compensation awards.

Comprehensive Income (Loss)

Comprehensive Income (Loss) Comprehensive income (loss) includes, in addition to net earnings, other items that are reported as direct adjustments to Manitowoc stockholders’ equity. These items are foreign currency translation adjustments, employee postretirement benefit adjustments and the change in fair value of certain derivative instruments.

Recent Accounting Changes and Pronouncements

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12 “Income Taxes (Topic 740).” The amendments in this ASU simplify accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The standard is effective for annual periods beginning after December 15, 2020. The Company is currently evaluating the impact the adoption of the ASU will have on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-15 “Intangibles – Goodwill and Other – Internal-use Software (Subtopic 250-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract.” The amendments in this ASU align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The standard is effective for annual periods beginning after December 15, 2019. The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements.

In February 2018, the FASB issued ASU No. 2018-02 “Income Statement-Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income. This new standard permits an entity to reclassify to retained earnings the tax effects stranded in accumulated other comprehensive income (loss) as a result of U.S. tax reform. The Company adopted this ASU as of January 1, 2019 and chose not to reclassify the stranded tax effects related to the U.S. tax reform change in the federal corporate tax rate from accumulated other comprehensive income (loss) to retained earnings. The Company has elected the portfolio approach to release stranded income tax effects in accumulated other comprehensive income (loss).

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses,” which requires the Company to measure all expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable supportable forecasts. The new guidance is applicable to financial assets measured at amortized cost, net investments in leases and certain off-balance sheet credit exposures. The standard is effective for annual periods beginning after December 15, 2019. The adoption of this ASU will not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued ASU 2016-02 - “Leases,” which is intended to improve financial reporting on leasing transactions. This was further clarified with technical corrections issued within ASU 2018-10 and ASU 2018-11. This standard requires a lessee to record on the balance sheet the assets and liabilities for the rights and obligations created by lease terms of more than 12 months. The Company adopted this ASU as of January 1, 2019. The adoption of this ASU did not have a material impact on the Company’s Consolidated Statement of Operations and Consolidated Statement of Cash Flows. The updated disclosures are included in Note 22, “Leases.”

Fair Value Measurement

ASC Topic 820-10 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820-10 classifies the inputs used to measure fair value into the following hierarchy:

Level 1

Unadjusted quoted prices in active markets for identical assets or liabilities

Level 2

Unadjusted quoted prices in active markets for similar assets or liabilities, or

Unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or

Inputs other than quoted prices that are observable for the asset or liability

Level 3

Unobservable inputs for the asset or liability

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Schedule of Estimated Useful Lives of Other Intangible Assets Subject to Amortization

The Company’s other intangible assets subject to amortization are amortized straight-line over the following estimated useful lives:

		Useful lives
Patents		20 years
Customer relationships		20 years

Schedule of Estimated Useful Lives of Property, Plant and Equipment

Property, plant and equipment are depreciated over the following estimated useful lives:

		Years
Building and improvements		2 - 43
Machinery, equipment and tooling		3 - 18
Furniture and fixtures		3 - 10
Computer hardware and software		2 - 10
Rental cranes		5 - 15

Revenues (Tables)

12 Months Ended

Dec. 31, 2019

Revenue From Contract With Customer [Abstract]

Schedule of Change In Customer Advances Balance

The table below shows the change in the customer advances balance for the year ended December 31, 2019 and 2018 which are included in current liabilities in the Consolidated Balance Sheet.

	2019			2018
Balance at beginning of period	$	9.6		$	12.7
Cash received in advance of satisfying performance obligation		112.2			96.5
Revenue recognized		(96.3	)		(98.5	)
Currency translation		0.3			(1.1	)
Balance at end of period	$	25.8		$	9.6

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Financial Assets and Liabilities Accounted for at Fair Value on a Recurring Basis by Level within the Fair Value Hierarchy

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value as of December 31, 2019 and 2018 by level within the fair value hierarchy. Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

	Fair Value as of December 31, 2019
	Level 1		Level 2		Level 3		Total
Current Assets:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1
Current Liabilities:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1

	Fair Value as of December 31, 2018
	Level 1		Level 2		Level 3		Total
Current Assets:
FX Forward Contracts	$	—	$	0.1	$	—	$	0.1
Current Liabilities:
FX Forward Contracts	$	—	$	1.8	$	—	$	1.8

Derivative Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2019

Foreign Currency Exchange Contracts

Derivative Instruments Gain Loss [Line Items]

Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts

The following table provides the amount of gains or losses recorded in the Consolidated Statement of Operations for FX Forward Contracts for the years ended December 31, 2019 and 2018.

	Recognized Location	2019		2018			2017
Designated	Cost of sales	$	3.1	$	5.0		$	0.6
Non-Designated	Other income (expense) - net		3.9		(1.9	)		(0.8	)

Inventories (Tables)

12 Months Ended

Dec. 31, 2019

Inventory Disclosure [Abstract]

Schedule of the components of inventories

The components of inventories as of December 31, 2019 and 2018 are summarized as follows:

	2019			2018
Raw materials	$	156.3		$	159.2
Work-in-process		116.3			112.0
Finished goods		239.4			238.0
Total inventories		512.0			509.2
Excess and obsolete inventory reserve		(50.6	)		(56.1	)
Inventories — net	$	461.4		$	453.1

Property, Plant and Equipment (Tables)

12 Months Ended

Dec. 31, 2019

Property Plant And Equipment [Abstract]

Components of Property, Plant and Equipment

The components of property, plant and equipment as of December 31, 2019 and 2018 are summarized as follows:

	2019			2018
Land	$	24.0		$	24.1
Building and improvements		197.3			195.3
Machinery, equipment and tooling		274.2			269.4
Furniture and fixtures		18.5			16.4
Computer hardware and software		119.3			117.1
Rental cranes		77.7			84.0
Construction in progress		11.2			9.6
Total cost		722.2			715.9
Less accumulated depreciation		(432.3	)		(427.0	)
Property, plant and equipment — net	$	289.9		$	288.9

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill And Intangible Assets Disclosure [Abstract]

Changes in goodwill by reportable segment

The changes in carrying amount of goodwill for the years ended December 31, 2019 and 2018 are as follows:

	Americas		EURAF			MEAP			Consolidated
Balance as of January 1, 2018	$	166.5	$	85.9		$	68.9		$	321.3
Foreign currency impact		—		(3.7	)		(2.6	)		(6.3	)
Goodwill impairment		—		(82.2	)		—			(82.2	)
Net balance as of December 31, 2018		166.5		—			66.3			232.8
Foreign currency impact		—		—			(0.3	)		(0.3	)
Net balance as of December 31, 2019	$	166.5	$	—		$	66.0		$	232.5

Gross carrying amount and accumulated amortization of the company's intangible assets other than goodwill

The gross carrying amount and accumulated amortization of the Company’s intangible assets other than goodwill are as follows as of December 31, 2019 and 2018.

	December 31, 2019							December 31, 2018
	Gross Carrying Amount		Accumulated Amortization Amount			Net Book Value		Gross Carrying Amount		Accumulated Amortization Amount			Net Book Value
Trademarks and tradenames	$	95.3	$	—		$	95.3	$	96.7	$	—		$	96.7
Customer relationships		10.0		(8.5	)		1.5		10.1		(8.4	)		1.7
Patents		29.5		(28.7	)		0.8		29.8		(29.0	)		0.8
Distribution network		18.7		—			18.7		18.9		—			18.9
Net balance	$	153.5	$	(37.2	)	$	116.3	$	155.5	$	(37.4	)	$	118.1

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2019

Payables And Accruals [Abstract]

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses as of December 31, 2019 and 2018 are summarized as follows:

	2019		2018
Trade accounts payable	$	187.1	$	249.2
Employee-related expenses		56.6		59.5
Accrued vacation		20.2		24.3
Miscellaneous accrued expenses		76.9		92.2
Total accounts payable and accrued expenses	$	340.8	$	425.2

Debt (Tables)

12 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Schedule of outstanding debt

Outstanding debt as of December 31, 2019 and 2018 is summarized as follows:

	2019			2018
Senior secured asset based revolving credit facility	$	—		$	—
Senior secured second lien notes due 2021		—			254.2
Senior secured second lien notes due 2026		300.0			—
Other		16.7			21.2
Deferred financing costs		(4.5	)		(2.3	)
Total debt		312.2			273.1
Short-term borrowings and current portion of long-term debt		(3.8	)		(6.4	)
Long-term debt	$	308.4		$	266.7

Schedule of revolving credit facility bear interest at variable rate based upon average quarterly availability

Borrowings under the ABL Revolving Credit Facility bear interest at a variable rate using either the Alternative Base Rate or the Eurodollar and Overnight London Interbank Offer Rate (“LIBOR”). The variable interest rate is based upon the average quarterly availability as of the most recent determination date as follows:

Average quarterly availability	Alternative base rate spread	Eurodollar and overnight LIBOR spread
≥ 50% of Aggregate Commitment	0.25%	1.25%
< 50% of Aggregate Commitment	0.50%	1.50%

Schedule of aggregate future maturities of outstanding debt obligations

The aggregate scheduled future maturities of outstanding debt obligations as of December 31, 2019 is as follows:

Year
2020	$	3.8
2021		10.5
2022		1.7
2023		—
2024		—
Thereafter		300.7
Total	$	316.7

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Summary of Income (Loss) from Continuing Operations Before Income Taxes

Income (loss) from continuing operations before income taxes for the years ended December 31, 2019, 2018 and 2017 is summarized as follows:

	2019			2018			2017
Income (loss) from continuing operations before income taxes:
U.S.	$	(10.0	)	$	(76.4	)	$	(98.5	)
Non-U.S.		69.0			4.7			59.0
Total	$	59.0		$	(71.7	)	$	(39.5	)

Schedule of Income Tax Expense (Benefit)

Income tax provision (benefit) for the years ended December 31, 2019, 2018 and 2017 is summarized as follows:

	2019			2018			2017
Current:
U.S. Federal and state	$	(0.7	)	$	(7.3	)	$	(12.8	)
Non-U.S.		11.6			13.6			7.4
Total current	$	10.9		$	6.3		$	(5.4	)
Deferred:
U.S. Federal and state	$	0.2		$	(6.2	)	$	(7.0	)
Non-U.S.		1.3			(4.9	)		(37.1	)
Total deferred	$	1.5		$	(11.1	)	$	(44.1	)
Income tax provision (benefit)	$	12.4		$	(4.8	)	$	(49.5	)

Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations

The U.S. federal statutory income tax rate is reconciled to the Company’s effective income tax rate for continuing operations for the years ended December 31, 2019, 2018 and 2017 as follows:

	2019			2018			2017
U.S. federal income tax at statutory rate		21.0	%		21.0	%		35.0	%
U.S. state income tax provision		(0.2	)		4.3			16.3
Manufacturing & research incentives		(5.2	)		2.4			7.9
Taxes on non-U.S. income which differ from the U.S. statutory rate		(4.4	)		(3.2	)		41.5
Adjustments for unrecognized tax benefits		(2.2	)		9.6			0.5
Adjustments for valuation allowances		7.6			(1.8	)		287.7
U.S. Tax Reform		6.9			2.5			(228.3	)
Goodwill impairment		—			(24.6	)		—
Other items		(2.5	)		(3.6	)		(35.4	)
Effective income tax rate		21.0	%		6.6	%		125.2	%

Schedules of Deferred Tax Assets (Liabilities)

Temporary differences and carryforwards that give rise to deferred tax assets and liabilities include the following items:

	2019			2018
Non-current deferred income tax assets (liabilities):
Inventories	$	24.3		$	22.7
Accounts receivable		(3.7	)		(4.2	)
Property, plant and equipment		(8.2	)		(14.0	)
Intangible assets		(34.1	)		(34.8	)
Deferred employee benefits		39.8			40.7
Product warranty reserves		8.6			6.6
Product liability reserves		3.0			4.0
Tax credits		5.4			7.1
Loss and other tax attribute carryforwards		125.7			137.8
Deferred revenue		5.8			5.1
Other		11.9			4.2
Total non-current deferred income tax assets		178.5			175.2
Less valuation allowance		(157.1	)		(153.1	)
Net deferred income tax assets, non-current	$	21.4		$	22.1

The net deferred tax assets are reflected in the Consolidated Balance Sheets for the years ended December 31, 2019 and 2018 as follows:

	2019			2018
Long-term income tax assets, included in other non-current assets	$	26.9		$	27.8
Long-term deferred income tax liability		(5.5	)		(5.7	)
Net deferred income tax asset	$	21.4		$	22.1

Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination

The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction, U.S. state and non-U.S. jurisdictions. The following table provides the open tax years for which the Company could be subject to income tax examination by the tax authorities in its major jurisdictions:

Jurisdiction		Open Years
U.S. Federal		2016 — 2019
China		2009 — 2019
France		2016 — 2019
Germany		2015 — 2019

Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits for the years ended December 31, 2019, 2018 and 2017 is as follows:

	2019			2018			2017
Balance at beginning of year	$	12.8		$	19.5		$	21.5
Additions based on tax positions related to the current year		0.5			0.3			0.9
Additions for tax positions of prior years		0.3			0.5			4.9
Reductions for tax positions of prior years		—			(1.7	)		(0.5	)
Reductions based on settlements with taxing authorities		(0.6	)		(0.6	)		(6.7	)
Reductions for lapse of statute		(1.5	)		(5.2	)		(0.6	)
Balance at end of year	$	11.5		$	12.8		$	19.5

Earnings (Loss) Per Share (Tables)

12 Months Ended

Dec. 31, 2019

Earnings Per Share [Abstract]

Reconciliation of the average shares outstanding used to compute basic and diluted earnings per share

The following is a reconciliation of the average shares outstanding used to compute basic and diluted earnings per share:

	2019		2018		2017
Basic weighted average common shares outstanding		35,487,358		35,513,162		35,111,594
Effect of dilutive securities - stock awards		154,442		—		743,308
Diluted weighted average common shares outstanding		35,641,800		35,513,162		35,854,902

Equity (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Schedule of Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss as of December 31, 2019 and 2018 are as follows:

	2019			2018
Foreign currency translation	$	(81.1	)	$	(80.1	)
Derivative instrument fair market value, net of income tax provision of $0.0 and $0.0		—			(0.3	)
Employee pension and postretirement benefit adjustments, net of income benefit of $13.7 and $13.5		(39.9	)		(36.2	)
Total accumulated other comprehensive loss	$	(121.0	)	$	(116.6	)

A reconciliation of the changes in accumulated other comprehensive loss, net of income tax, by component for the years ended December 31, 2018 and 2019 are as follows:

	Gains (Losses) on Cash Flow Hedges			Pension & Postretirement			Foreign Currency Translation			Total
Balance at December 31, 2017	$	0.1		$	(45.1	)	$	(52.4	)	$	(97.4	)
Other comprehensive income (loss) before reclassifications		(5.4	)		3.5			(27.7	)		(29.6	)
Amounts reclassified from accumulated other comprehensive income		5.0			5.4			—			10.4
Net current period other comprehensive income (loss)		(0.4	)		8.9			(27.7	)		(19.2	)
Balance at December 31, 2018		(0.3	)		(36.2	)		(80.1	)		(116.6	)
Other comprehensive loss before reclassifications		(2.8	)		(5.5	)		(1.0	)		(9.3	)
Amounts reclassified from accumulated other comprehensive income		3.1			1.8			—			4.9
Net current period other comprehensive income (loss)		0.3			(3.7	)		(1.0	)		(4.4	)
Balance at December 31, 2019	$	—		$	(39.9	)	$	(81.1	)	$	(121.0	)

Reconciliation of reclassifications out of accumulated other comprehensive income (loss), net of income taxes

A reconciliation of the reclassifications out of accumulated other comprehensive loss, net of income taxes, for the years ended December 31, 2019, 2018 and 2017 are as follows:

	Amount Reclassified from Accumulated Other Comprehensive Loss
	2019				2018			2017			Recognized Location
Gains and losses on cash flow hedges
FX Forward Contracts	$	(3.1	)	$	(5.0	)	$	(0.7	)		Cost of sales
Total before income taxes		(3.1	)		(5.0	)		(0.7	)
Income tax provision		—			—			—
Total, net of income taxes	$	(3.1	)	$	(5.0	)	$	(0.7	)
Amortization of pension and postretirement items
Actuarial losses	$	(4.6	)	$	(5.0	)	$	(5.2	)	(a)	Other expense - net
Amortization of prior service cost		2.8			2.7			1.3		(a)	Other expense - net
Pension settlement charge		—			(4.5	)		—		(a)	Other expense - net
Total before income taxes		(1.8	)		(6.8	)		(3.9	)
Income tax benefit		—			1.4			4.2
Total, net of income taxes	$	(1.8	)	$	(5.4	)	$	0.3

Total reclassifications for the period, net of income taxes	$	(4.9	)	$	(10.4	)	$	(0.4	)

These accumulated other comprehensive loss components are components of net periodic pension cost (see Note 21, “Employee Benefit Plans,” for further details).

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Summary of the Company's Stock Option Activity

A summary of the Company’s stock option activity is as follows:

	Shares			Weighted Average Exercise Price Per Share		Aggregate Intrinsic Value
Options outstanding as of December 31, 2018		956,164			21.58
Granted		210,243			18.40
Exercised		(58,404	)		6.57
Forfeited		(17,164	)		23.81
Cancelled		(24,868	)		21.18
Options outstanding as of December 31, 2019		1,065,971		$	21.75	$	0.4

Options exercisable as of December 31, 2019		623,487		$	20.96	$	0.4

Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant

The fair value of each option grant was estimated at the date of grant using the following assumptions:

	2019			2018			2017
Expected life (years)		6.5			6.5			6.5
Risk-free interest rate		2.6	%		2.8	%		2.2	%
Expected volatility		39.8	%		43.7	%		45.0	%
Expected dividend yield		—	%		—	%		—	%

Restricted Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Nonvested Share Activity

A summary of activity for restricted stock units is as follows:

	Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2018		219,917			25.37
Granted		229,044			18.39
Vested		(154,295	)		20.26
Forfeited		(4,103	)		27.34
Unvested as of December 31, 2019		290,563		$	22.55

Performance Shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant

The fair value of each total shareholder return performance stock unit was estimated at the date of grant using the following assumptions:

	2019			2018			2017
Correlation		32.5	%		29.5	%		31.6	%
Risk-free interest rate		2.5	%		2.4	%		1.5	%
Expected volatility		47.0	%		33.8	%		35.0	%
Expected dividend yield		—	%		—	%		—	%

Schedule of Nonvested Share Activity

A summary of activity for performance stock units is as follows:

	Shares			Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2018		337,124			28.02
Granted		228,037			22.01
Vested		(74,315	)		25.73
Forfeited		(78,441	)		20.24
Unvested as of December 31, 2019		412,405		$	26.58

Segments (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Schedule of Information by Reportable Segment

The following table shows information by reportable segment for the years ended December 31, 2019, 2018 and 2017:

	2019		2018			2017
Net Sales
Americas	$	969.7	$	882.7		$	693.6
EURAF		644.9		680.6			628.9
MEAP		219.5		283.5			258.8
Total	$	1,834.1	$	1,846.8		$	1,581.3
Segment Operating Income (Loss)
Americas	$	113.4	$	58.8		$	6.8
EURAF		3.8		(68.2	)		5.1
MEAP		22.6		31.5			33.1
Total	$	139.8	$	22.1		$	45.0
Depreciation
Americas	$	14.5	$	14.0		$	15.1
EURAF		15.1		15.3			15.0
MEAP		2.4		3.7			3.8
Corporate		3.0		3.1			4.2
Total	$	35.0	$	36.1		$	38.1
Capital Expenditures
Americas	$	13.2	$	9.4		$	10.6
EURAF		19.0		16.3			14.3
MEAP		2.9		3.4			3.9
Corporate		—		2.6			0.1
Total	$	35.1	$	31.7		$	28.9

Schedule of Reconciliation of the Company's Segment Operating Income (Loss)

A reconciliation of the Company’s segment operating income (loss) to the Consolidated Statement of Operations for the years ended December 31, 2019, 2018 and 2017 are summarized as follows:

	2019			2018			2017
Segment operating income (loss)	$	139.8		$	22.1		$	45.0
Unallocated corporate expenses		(31.3	)		(37.5	)		(33.0	)
Unallocated restructuring expense		(0.1	)		(3.9	)		(3.6	)
Total operating income (loss)	$	108.4		$	(19.3	)	$	8.4

Schedule of Net Sales and Property, Plant and Equipment by Geographic Area

Net sales and property, plant and equipment by geographic area as of and for the years ended December 31 are summarized below.

	Net Sales						Property, Plant and Equipment
	2019		2018		2017		2019		2018
United States	$	860.4	$	796.9	$	618.5	$	109.3	$	110.6
Europe		619.8		659.9		601.3		150.4		145.2
Other		353.9		390.0		361.5		30.2		33.1
Total	$	1,834.1	$	1,846.8	$	1,581.3	$	289.9	$	288.9

Schedule of Net Sales By Product

Net sales by product for the years ended December 31, 2019, 2018 and 2017 are summarized as follows:

	2019		2018		2017
Cranes	$	1,498.6	$	1,509.9	$	1,270.5
Aftermarket parts and other*		335.5		336.9		310.8
Total net sales	$	1,834.1	$	1,846.8	$	1,581.3

* Other revenue consists of revenue related to miscellaneous Crane Care services such as

training and field service work.

Guarantees (Tables)

12 Months Ended

Dec. 31, 2019

Guarantees [Abstract]

Summary of Warranty Activity

Below is a table summarizing the warranty activity for the years ended December 31, 2019, 2018 and 2017:

	2019			2018			2017
Balance at beginning of period	$	47.8		$	44.5		$	44.1
Accruals for warranties issued during the period		47.3			38.0			34.5
Settlements made (in cash or in kind) during the period		(34.2	)		(33.8	)		(36.9	)
Currency translation		(0.3	)		(0.9	)		2.8
Balance at end of period	$	60.6		$	47.8		$	44.5

Restructuring (Tables)

12 Months Ended

Dec. 31, 2019

Restructuring And Related Activities [Abstract]

Summary of all restructuring activities

The following is a summary of the Company's restructuring activities for the years ended December 31, 2019, 2018 and 2017:

	2019			2018			2017
Balance at beginning of period	$	3.3		$	5.6		$	8.2
Restructuring expenses		9.8			12.9			27.2
Use of reserve		(10.9	)		(15.1	)		(28.8	)
Reserve reclassification		(0.2	)		—			(1.2	)
Currency translation		—			(0.1	)		0.2
Balance at end of period	$	2.0		$	3.3		$	5.6

Employee Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Schedule of Components of Period Benefit Costs

The components of periodic benefit costs for the years ended December 31, 2019, 2018 and 2017 are as follows:

	US Pension Plans									Non-US Pension Plans									Postretirement Medical and Other
	2019			2018			2017			2019			2018			2017			2019			2018			2017
Service cost - benefits earned during the year	$	—		$	—		$	—		$	1.8		$	1.8		$	1.9		$	0.2		$	0.2		$	0.3
Interest cost of projected benefit obligation		5.1			5.2			5.3			2.2			2.1			2.1			0.8			0.8			1.0
Expected return on assets		(4.3	)		(5.7	)		(4.9	)		(1.4	)		(1.4	)		(1.5	)		—			—			—
Amortization of prior service cost		—			—			—			0.1			0.1			0.1			(2.8	)		(2.8	)		(1.4	)
Amortization of actuarial net loss (gain)		3.3			2.9			3.2			1.3			1.3			1.6			—			0.8			0.4
Pension settlement charge		—			4.5			—			—			—			—			—			—			—
Net periodic benefit cost	$	4.1		$	6.9		$	3.6		$	4.0		$	3.9		$	4.2		$	(1.8	)	$	(1.0	)	$	0.3
Weighted average assumptions:
Discount rate		4.3	%		3.8	%		4.2	%		2.5	%		2.2	%		2.1	%		4.1	%		3.3	%		3.8	%
Expected return on plan assets		5.2	%		5.3	%		4.7	%		3.5	%		2.7	%		3.4	%	N/A			N/A			N/A
Rate of compensation increase	N/A			N/A			N/A				3.6	%		3.5	%		2.6	%	N/A			N/A			N/A

Reconciliation of the Changes in Benefit Obligation, the Changes in Plan Assets, and the Funded Status

The following is a reconciliation of the changes in benefit obligation, plan assets, and funded status as of December 31, 2019 and 2018:

	US Pension Plans						Non-US Pension Plans						Postretirement Medical and Other
	2019			2018			2019			2018			2019			2018
Change in Benefit Obligation
Benefit obligation, beginning of year	$	130.5		$	162.3		$	81.9		$	89.5		$	20.7		$	28.9
Service cost		—			—			1.8			1.8			0.2			0.2
Interest cost		5.1			5.2			2.2			2.1			0.8			0.8
Participant contributions		—			—			—			—			0.4			0.7
Plan amendments		—			—			—			—			—			—
Actuarial (gain) loss		13.8			(9.2	)		8.3			(3.0	)		(1.5	)		(7.2	)
Currency translation adjustment		—			—			1.1			(4.6	)		—			—
Pension settlement		—			(18.9	)		—			—			—			—
Benefits paid		(7.1	)		(8.8	)		(4.7	)		(3.9	)		(2.2	)		(2.7	)
Benefit obligation, end of year	$	142.3		$	130.5		$	90.6		$	81.9		$	18.4		$	20.7
Change in Plan Assets
Fair value of plan assets, beginning of year	$	84.9		$	116.2		$	40.1		$	45.1		$	—		$	—
Actual return on plan assets		16.8			(8.9	)		4.2			(1.4	)		—			—
Employer contributions		5.0			5.3			4.0			2.8			1.8			2.0
Participant contributions		—			—			—			—			0.4			0.7
Currency translation adjustment		—			—			1.6			(2.5	)		—			—
Pension settlement		—			(18.9	)		—			—			—			—
Benefits paid		(7.1	)		(8.8	)		(4.7	)		(3.9	)		(2.2	)		(2.7	)
Fair value of plan assets, end of year		99.6			84.9			45.2			40.1			—			—
Funded status	$	(42.7	)	$	(45.6	)	$	(45.4	)	$	(41.8	)	$	(18.4	)	$	(20.7	)
Amounts recognized in the Consolidated Balance sheet at December 31
Pension asset	$	—		$	—		$	—		$	—		$	—		$	—
Pension obligation		(42.7	)		(45.6	)		(45.4	)		(41.8	)		—			—
Postretirement medical and other benefit obligations		—			—			—			—			(18.4	)		(20.7	)
Net amount recognized	$	(42.7	)	$	(45.6	)	$	(45.4	)	$	(41.8	)	$	(18.4	)	$	(20.7	)
Weighted-Average Assumptions
Discount rate		3.3	%		4.3	%		1.5	%		2.2	%		2.9	%		4.1	%
Expected return on plan assets		5.2	%		5.3	%		3.5	%		2.7	%	N/A			N/A
Rate of compensation increase	N/A			N/A				3.6	%		3.5	%	N/A			N/A

Amounts Recognized in Accumulated Other Comprehensive Loss

Amounts recognized in accumulated other comprehensive loss as of December 31, 2019 and 2018, are summarized as follows:

	Pensions						Postretirement Medical and Other
	2019			2018			2019		2018
Net actuarial gain (loss)	$	(61.9	)	$	(59.3	)	$	1.9	$	0.4
Prior service credit (cost)		(0.5	)		(0.5	)		6.9		9.7
Total amount recognized	$	(62.4	)	$	(59.8	)	$	8.8	$	10.1

Summary of the Sensitivity of Retirement Obligations and Retirement Benefit Costs of Plans to Changes in the Key Assumptions

The following table summarizes the sensitivity of our December 31, 2019 retirement obligations and 2020 retirement benefit costs of our plans to changes in the key assumptions used to determine those results:

Change in assumption:	Estimated increase (decrease) in 2020 pension cost			Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019			Estimated decrease in 2020 Other Postretirement Benefit costs			Estimated increase (decrease) in Other Postretirement Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	$	(0.8	)	$	(14.3	)	N/A			$	(0.6	)
0.50% decrease in discount rate		0.9			15.7			(0.1	)		0.6
0.50% increase in long-term return on assets		(0.7	)	N/A			N/A			N/A
0.50% decrease in long-term return on assets		0.7		N/A			N/A			N/A
1% increase in medical trend rates	N/A			N/A			N/A				0.7
1% decrease in medical trend rates	N/A			N/A				(0.1	)		(0.6	)

Schedule of the Weighted-Average Asset Allocations of the Pension Plans

The weighted-average asset allocations of the U.S. pension plans as of December 31, 2019 and 2018, by asset category are as follows:

	2019			2018
Equity		50.4	%		47.8	%
Fixed income		48.9	%		51.4	%
Other		0.7	%		0.8	%
Total		100.0	%		100.0	%

The weighted-average asset allocations of the Non-U.S. pension plans as of December 31, 2019 and 2018, by asset category are as follows:

	2019			2018
Equity		0.0	%		36.1	%
Fixed income		31.9	%		31.6	%
Other*		68.1	%		32.3	%
Total		100.0	%		100.0	%
*Includes diversified investments that have equity and fixed income holdings.

Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class

The actual and target allocations for the pension assets as of December 31, 2019, by asset class, are as follows:

	Target Allocations						Weighted Average Asset Allocations
	U.S. Plans			Non-U.S. Plans			U.S. Plans			Non-U.S. Plans
Equity Securities		50	%		—	%		50.4	%		0.0	%
Debt Securities		50	%	40%				48.9	%		31.9	%
Other		—	%	60%				0.7	%		68.1	%

Schedule of Plan Assets Using the Fair Value Hierarchy

The following table presents the Company’s plan assets using the fair value hierarchy as of December 31, 2019 and 2018. The fair value hierarchy has three levels based on the reliability of the inputs used to determine fair value. Level 1 refers to fair values determined based on quoted prices in active markets for identical assets. Level 2 refers to fair values estimated using significant other observable inputs, and Level 3 includes fair values estimated using significant non-observable inputs.

	December 31, 2019
Assets	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)		Net Asset Value ("NAV")		Total
Cash and cash equivalents	$	2.4	$	—	$	—	$	—	$	2.4
Insurance group annuity contracts		—		—		12.6		—		12.6
Common/collective trust funds — Corporate and other non-government debt		—		—		—		22.9		22.9
Common/collective trust funds — Government, corporate and other non-government debt		—		—		—		40.2		40.2
Common/collective trust funds — Corporate equity		—		—		—		50.3		50.3
Common/collective trust funds — Customized strategy		—		—		—		16.4		16.4
Total	$	2.4	$	—	$	12.6	$	129.8	$	144.8

	December 31, 2018
Assets	Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Unobservable Inputs (Level 3)		Net Asset Value ("NAV")		Total
Cash and cash equivalents	$	1.7	$	—	$	—	$	—	$	1.7
Insurance group annuity contracts		—		—		12.0		—		12.0
Common/collective trust funds — Government, corporate and other non-government debt		—		—		—		56.3		56.3
Common/collective trust funds — Corporate equity		—		—		—		55.0		55.0
Total	$	1.7	$	—	$	12.0	$	111.3	$	125.0

Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year

A reconciliation of the fair value measurements of plan assets using significant unobservable inputs (Level 3) from the beginning of the year to the end of the year is as follows:

	Insurance Contracts Year Ended December 31,
	2019			2018
Beginning Balance	$	12.0		$	14.4
Actual return on assets		1.1			(0.3	)
Benefit payments		(1.0	)		(1.3	)
Foreign currency impact		0.5			(0.8	)
Ending Balance	$	12.6		$	12.0

Schedule of Projected Future Benefit Payments from the Plans

Projected future benefit payments from the plans as of December 31, 2019 are estimated as follows:

	U.S Pension Plans		Non-U.S. Pension Plans		Postretirement Medical and Other
2020	$	8.5	$	3.1	$	2.1
2021		8.6		2.9		2.0
2022		8.7		3.1		1.9
2023		8.8		3.5		1.8
2024		8.8		3.6		1.7
Thereafter		43.0		21.1		6.6
Total	$	86.4	$	37.3	$	16.1

Schedule of Fair Value of Plan Assets for which the Accumulated Benefit Obligation is in Excess of Plan Assets

The fair value of plan assets for which the accumulated benefit obligation is in excess of the plan assets as of December 31, 2019 and 2018 is as follows:

	U.S Pension Plans				Non U.S. Pension Plans
	2019		2018		2019		2018
Projected benefit obligation	$	142.3	$	130.5	$	90.5	$	81.9
Accumulated benefit obligation		142.3		130.5		86.4		78.1
Fair value of plan assets		99.6		84.9		45.2		40.1

Leases (Tables)

12 Months Ended

Dec. 31, 2019

Leases [Abstract]

Summary of Components of Lease Expense

The components of lease expense for the year ended December 31, 2019 are summarized as follows:

	2019
Operating lease cost	$	14.4
Variable lease cost*		1.4
Total lease cost	$	15.8
*Includes short-term leases, which are immaterial.

Summary of Supplemental Consolidated Balance Sheet Information Related to Leases

Supplemental Consolidated Balance Sheet information related to leases as of December 31, 2019 are summarized as follows:


Operating lease right-of-use assets	$	47.6

Other liabilities	$	10.4
Operating lease liabilities		37.6
Total operating lease liabilities	$	48.0

Summary of Maturities of Operating Lease Liabilities

Maturities of operating lease liabilities as of December 31, 2019 are summarized as follows:

Year
2020	$	12.1
2021		10.2
2022		8.3
2023		6.0
2024		4.5
Thereafter		16.5
Total lease payments		57.6
Less: imputed interest		(9.6	)
Present value of lease liabilities	$	48.0

Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Data

The following tables present select quarterly financial data for 2019 and 2018:

Historical	2019									2018
	First			Second		Third		Fourth		First			Second			Third			Fourth
Statements of operations:
Net sales	$	418.0		$	504.7	$	448.0	$	463.4	$	386.1		$	495.3		$	450.1		$	515.3
Cost of sales		337.8			409.5		359.6		383.1		317.7			404.8			370.1			426.1
Gross profit		80.2			95.2		88.4		80.3		68.4			90.5			80.0			89.2
Operating income (loss)		16.2			41.9		32.5		17.8		1.7			24.1			16.9			(62.0	)
Income (loss) from continuing operations before income taxes		(23.4	)		49.9		21.2		11.3		(6.1	)		8.7			0.8			(75.1	)
Provision (benefit) for income taxes		3.3			3.9		3.1		2.1		3.9			(1.2	)		(10.7	)		3.2
Net income (loss) from continuing operations		(26.7	)		46.0		18.1		9.2		(10.0	)		9.9			11.5			(78.3	)
Loss from discontinued operations, net of income taxes		—			—		—		—		—			(0.2	)		—			—
Net income (loss)	$	(26.7	)	$	46.0	$	18.1	$	9.2	$	(10.0	)	$	9.7		$	11.5		$	(78.3	)
Basic (loss) income per share:
Net income (loss) income from continuing operations	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.28		$	0.32		$	(2.20	)
Loss from discontinued operations		—			—		—		—		—			(0.01	)		—			—
Net income (loss) per share	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Diluted (loss) income per share:
Net income (loss) from continuing operations	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Loss from discontinued operations		—			—		—		—		—			—			—			—
Net income (loss) per share	$	(0.75	)	$	1.29	$	0.51	$	0.26	$	(0.28	)	$	0.27		$	0.32		$	(2.20	)
Dividends per common share	$	—		$	—	$	—	$	—	$	—		$	—		$	—		$	—

Company and Basis of Presentation - Narrative (Details) crane in Thousands	12 Months Ended
	Dec. 31, 2019 crane
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Period of providing high-quality, customer-focused products and support services	117 years
Number of cranes serviced	149

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Other Intangible Assets Subject to Amortization (Details)	12 Months Ended
	Dec. 31, 2019
Patents
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	20 years
Customer Relationships
Estimated useful lives of other intangible assets
Finite-lived intangible asset, useful life	20 years

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property, Plant and Equipment (Details)	12 Months Ended
	Dec. 31, 2019
Building and Improvements \| Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	2 years
Building and Improvements \| Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	43 years
Machinery, Equipment and Tooling \| Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Machinery, Equipment and Tooling \| Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	18 years
Furniture and Fixtures \| Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	3 years
Furniture and Fixtures \| Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Computer Hardware and Software \| Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	2 years
Computer Hardware and Software \| Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	10 years
Rental Cranes \| Minimum
Property, Plant and Equipment
Property, plant and equipment, useful lives	5 years
Rental Cranes \| Maximum
Property, Plant and Equipment
Property, plant and equipment, useful lives	15 years

Summary of Significant Accounting Policies - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2019 USD ($) estimate	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment — net	$ 289.9	$ 288.9
Number of estimates upon which the product liability reserves are based \| estimate	2
Research and development costs	$ 31.1	35.2	$ 37.9
Assets Leased to Others
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Property, plant and equipment — net	$ 51.2	$ 49.4

Revenues - Schedule of Change In Customer Advances Balance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue From Contract With Customer [Abstract]
Balance at beginning of period	$ 9.6	$ 12.7
Cash received in advance of satisfying performance obligation	112.2	96.5
Revenue recognized	(96.3)	(98.5)
Currency translation	0.3	(1.1)
Balance at end of period	$ 25.8	$ 9.6

Fair Value of Financial Instruments - Financial assets and liabilities accounted for at fair value on a recurring basis by level within the fair value hierarchy (Details) - Estimate of Fair Value Measurement - Fair Value, Measurements, Recurring - FX Forward Contracts - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	$ 0.1	$ 0.1
Derivative liabilities, current	0.1	1.8
Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Derivatives assets, current	0.1	0.1
Derivative liabilities, current	$ 0.1	$ 1.8

Fair Value of Financial Instruments - Narrative (Details) - Senior Notes Due 2026 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Mar. 25, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Debt instruments at fair value	$ 316.1
Interest rate, stated percentage (as a percent)	9.00%	9.00%
Debt instrument maturity date	Apr. 01, 2026

Derivative Financial Instruments - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Derivatives Fair Value [Line Items]
Net unrealized gain (losses) net of income tax	$ 0	$ (300,000)
FX Forward Contracts
Derivatives Fair Value [Line Items]
Derivative, notional amount	$ 32,600,000	76,800,000
Derivative remaining maturity period	1 year
Derivative net current liability	$ 0	$ 1,700,000

Derivative Financial Instruments - Summary of Gains or Losses Recorded in Consolidated Statement of Operations for FX Forward Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Designated \| Cost of Sales
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ 3.1	$ 5.0	$ 0.6
Non-Designated \| Other Income (Expense) - Net
Derivative Instruments Gain Loss [Line Items]
Gains (loss) on foreign currency exchange contracts	$ 3.9	$ (1.9)	$ (0.8)

Inventories - Components of Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Inventory Disclosure [Abstract]
Raw materials	$ 156.3	$ 159.2
Work-in-process	116.3	112.0
Finished goods	239.4	238.0
Total inventories	512.0	509.2
Excess and obsolete inventory reserve	(50.6)	(56.1)
Inventories — net	$ 461.4	$ 453.1

Notes Receivable - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Receivables [Abstract]
Notes receivable, current	$ 17.4	$ 19.4
Notes receivable, long term	16.3	17.0
Notes receivable, write-off	$ 2.8	$ 3.6

Property, Plant and Equipment - Components of property, plant and equipment (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment
Total cost	$ 722.2	$ 715.9
Less accumulated depreciation	(432.3)	(427.0)
Property, plant and equipment — net	289.9	288.9
Land
Property, Plant and Equipment
Total cost	24.0	24.1
Building and Improvements
Property, Plant and Equipment
Total cost	197.3	195.3
Machinery, Equipment and Tooling
Property, Plant and Equipment
Total cost	274.2	269.4
Furniture and Fixtures
Property, Plant and Equipment
Total cost	18.5	16.4
Computer Hardware and Software
Property, Plant and Equipment
Total cost	119.3	117.1
Rental Cranes
Property, Plant and Equipment
Total cost	77.7	84.0
Property, plant and equipment — net	51.2	49.4
Construction in Progress
Property, Plant and Equipment
Total cost	$ 11.2	$ 9.6

Property, Plant and Equipment - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment
Asset impairment expense	$ 0	$ 400,000
Other Income (Expense) – Net
Property, Plant and Equipment
Gain on assets held for sale	$ 3,500,000
Other Current Assets
Property, Plant and Equipment
Assets held for sale		$ 12,900,000

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and intangible asset impairment	$ 0	$ (82,200,000)
Non-cash goodwill and impairment charge		82,200,000
Amortization of intangible assets	300,000	$ 300,000	$ 800,000
Future amortization expense, 2020	300,000
Future amortization expense, 2021	300,000
Future amortization expense, 2022	$ 300,000

Goodwill and Other Intangible Assets - Changes in goodwill by reportable segment (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Goodwill
Balance at the beginning of the period	$ 232,800,000	$ 321,300,000
Foreign currency impact	(300,000)	(6,300,000)
Goodwill impairment	0	(82,200,000)
Net balance at the end of the period	232,500,000	232,800,000
Americas
Goodwill
Balance at the beginning of the period	166,500,000	166,500,000
Net balance at the end of the period	166,500,000	166,500,000
Europe and Africa ("EURAF")
Goodwill
Balance at the beginning of the period		85,900,000
Foreign currency impact		(3,700,000)
Goodwill impairment		(82,200,000)
Middle East and Asia Pacific ("MEAP")
Goodwill
Balance at the beginning of the period	66,300,000	68,900,000
Foreign currency impact	(300,000)	(2,600,000)
Net balance at the end of the period	$ 66,000,000.0	$ 66,300,000

Goodwill and Other Intangible Assets - Gross carrying amount and accumulated amortization of the company's intangible assets other than goodwill (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Intangible asset balances by major asset class
Intangible assets, gross (excluding goodwill)	$ 153.5	$ 155.5
Finite-lived intangible assets, amortization amount	(37.2)	(37.4)
Intangible assets, book value	116.3	118.1
Customer Relationships
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	10.0	10.1
Finite-lived intangible assets, amortization amount	(8.5)	(8.4)
Finite-lived intangible assets, book value	1.5	1.7
Patents
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	29.5	29.8
Finite-lived intangible assets, amortization amount	(28.7)	(29.0)
Finite-lived intangible assets, book value	0.8	0.8
Distribution Network
Intangible asset balances by major asset class
Finite-lived intangible assets, carrying amount	18.7	18.9
Finite-lived intangible assets, book value	18.7	18.9
Trademarks and Tradenames
Intangible asset balances by major asset class
Indefinite-lived intangible assets, book value	$ 95.3	$ 96.7

Accounts Payable and Accrued Expenses - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Payables And Accruals [Abstract]
Trade accounts payable	$ 187.1	$ 249.2
Employee-related expenses	56.6	59.5
Accrued vacation	20.2	24.3
Miscellaneous accrued expenses	76.9	92.2
Total accounts payable and accrued expenses	$ 340.8	$ 425.2

Debt - Schedule of outstanding debt (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Total debt	$ 312,200,000	$ 273,100,000
Deferred financing costs	(4,500,000)	(2,300,000)
Short-term borrowings and current portion of long-term debt	(3,800,000)	(6,400,000)
Long-term debt	308,400,000	266,700,000
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Senior secured asset based revolving credit facility	0	0
Senior Notes Due 2021
Debt Instrument [Line Items]
Total debt		254,200,000
Deferred financing costs	(3,100,000)
Senior Notes Due 2026
Debt Instrument [Line Items]
Total debt	300,000,000.0
Other
Debt Instrument [Line Items]
Total debt	$ 16,700,000	$ 21,200,000

Debt - Narrative (Details) - USD ($)		12 Months Ended
Debt - Narrative (Details) - USD ($)	Mar. 25, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Mar. 03, 2016
Debt Instrument [Line Items]
Debt instrument charge from refinancing		$ 25,000,000.0	$ 0	$ 0
Unamortized debt issuance costs		4,500,000	2,300,000
Carrying amount		$ 312,200,000	273,100,000
Period for which the entity will be able to comply with the financial covenants		12 months
Senior Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt	$ 300,000,000.0
Debt instrument interest rate	9.00%	9.00%
Debt instrument maturity date		Apr. 01, 2026
Interest on the notes		Interest on the 2026 Notes is payable in cash semi-annual in arrears on April 1 and October 1 of each year.
Carrying amount		$ 300,000,000.0
ABL Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 275,000,000.0				$ 225,000,000.0
Weighted average interest rate (as a percent)		4.15%
Line of credit outstanding		$ 0	0
Highest daily borrowing		39,700,000
Average borrowing		8,900,000
Excess capacity		206,400,000
Line of credit borrowing capacity		$ 210,400,000
ABL Revolving Credit Facility \| Eurodollar and Overnight LIBOR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		1.25%
ABL Revolving Credit Facility \| Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.25%
ABL Revolving Credit Facility \| Line of Credit
Debt Instrument [Line Items]
Debt term (in years)	5 years
ABL Revolving Credit Facility \| Letter of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 75,000,000.0
Line of credit outstanding		$ 4,000,000.0
ABL Revolving Credit Facility \| Letter of Credit \| German Borrowers
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 10,000,000.0
Senior Notes Due 2021
Debt Instrument [Line Items]
Debt instrument interest rate	12.75%
Maximum borrowing capacity under revolving credit facility	$ 260,000,000.0
Debt instrument call premium	16,600,000	16,600,000
Closing costs of debt	5,000,000.0
Accrued interest of debt	4,600,000
Debt instrument unamortized discount		5,300,000
Unamortized debt issuance costs		3,100,000
Carrying amount			254,200,000
AR Securitization Facility
Debt Instrument [Line Items]
Maximum borrowing capacity under revolving credit facility	$ 75,000,000.0
Other
Debt Instrument [Line Items]
Carrying amount		$ 16,700,000	$ 21,200,000
Weighted average interest rate (as a percent)		5.10%

Debt - Schedule of Revolving Credit Facility Bear Interest at Variable Rate Based Upon Average Quarterly Availability (Details) - ABL Revolving Credit Facility	12 Months Ended
	Dec. 31, 2019
Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.25%
Eurodollar and Overnight LIBOR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.25%
Greater Than or Equal to 50% of Aggregate Commitment \| Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.25%
Greater Than or Equal to 50% of Aggregate Commitment \| Eurodollar and Overnight LIBOR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.25%
Less Than 50% of Aggregate Commitment \| Alternative Base Rate Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	0.50%
Less Than 50% of Aggregate Commitment \| Eurodollar and Overnight LIBOR Spread
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	1.50%

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Details) $ in Millions	Dec. 31, 2019 USD ($)
Aggregate scheduled future maturities of outstanding debt obligations
2020	$ 3.8
2021	10.5
2022	1.7
Thereafter	300.7
Total	$ 316.7

Debt - Schedule of Aggregate Future Maturities of Outstanding Debt Obligations (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Debt Disclosure [Abstract]
Deferred financing costs	$ 4.5	$ 2.3

Accounts Receivable Securitization and Other Factoring Arrangements - Narrative (Details) € in Millions	12 Months Ended
	Dec. 31, 2019 USD ($)	Dec. 31, 2019 EUR (€)	Dec. 31, 2018 USD ($)	Dec. 31, 2018 EUR (€)	Dec. 31, 2017 USD ($)
Accounts Receivable Securitization
Accounts receivable balance sold	$ 149,000,000.0	€ 193.6	$ 863,500,000
Proceeds from collection of receivables	182,800,000	€ 193.6	781,600,000
Sales of trade receivables	$ 0		75,000,000.0
Average collection cycle for accounts receivable (in days) (less than)	60 days	60 days
Fair value of deferred purchase price notes	$ 0		71,500,000
Non-cash investing activities related to increase in deferred purchase price	0		$ 594,200,000		$ 538,100,000
Maximum availability under these programs \| €		€ 55.0		€ 45.0
Maximum
Accounts Receivable Securitization
Capacity of securitization program	$ 75,000,000.0

Income Taxes - Summary of Income (Loss) from Continuing Operations Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income (loss) from continuing operations before income taxes:
U.S.									$ (10.0)	$ (76.4)	$ (98.5)
Non-U.S.									69.0	4.7	59.0
Income (loss) from continuing operations before income taxes	$ 11.3	$ 21.2	$ 49.9	$ (23.4)	$ (75.1)	$ 0.8	$ 8.7	$ (6.1)	$ 59.0	$ (71.7)	$ (39.5)

Income Taxes - Schedule of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Current:
U.S. Federal and state									$ (0.7)	$ (7.3)	$ (12.8)
Non-U.S.									11.6	13.6	7.4
Total current									10.9	6.3	(5.4)
Deferred:
U.S. Federal and state									0.2	(6.2)	(7.0)
Non-U.S.									1.3	(4.9)	(37.1)
Total deferred									1.5	(11.1)	(44.1)
Income tax provision (benefit)	$ 2.1	$ 3.1	$ 3.9	$ 3.3	$ 3.2	$ (10.7)	$ (1.2)	$ 3.9	$ 12.4	$ (4.8)	$ (49.5)

Income Taxes - Reconciliation of the U.S. Federal Statutory Income Tax Rate to the Company's Effective Income Tax Rate for Continuing Operations (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Effective Income Tax Rate Continuing Operations Tax Rate Reconciliation [Abstract]
U.S. federal income tax at statutory rate (as a percent)	21.00%	21.00%	35.00%
U.S. state income tax provision (as a percent)	(0.20%)	4.30%	16.30%
Manufacturing & research incentives (as a percent)	(5.20%)	2.40%	7.90%
Taxes on non-U.S. income which differ from the U.S. statutory rate (as a percent)	(4.40%)	(3.20%)	41.50%
Adjustments for unrecognized tax benefits (as a percent)	(2.20%)	9.60%	0.50%
Adjustments for valuation allowances (as a percent)	7.60%	(1.80%)	287.70%
U.S. Tax Reform (as a percent)	6.90%	2.50%	(228.30%)
Goodwill impairment (as a percent)		(24.60%)
Other items (as a percent)	(2.50%)	(3.60%)	(35.40%)
Effective income tax rate (as a percent)	21.00%	6.60%	125.20%

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
Income Taxes - Narrative (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Operating Loss Carryforwards [Line Items]
Federal income tax at statutory rate (as a percent)	21.00%	21.00%	35.00%
Tax cuts and jobs act of 2017 total transition tax obligation		$ 57,200,000
Tax cuts and jobs act of 2017 related to GILTI provisional income tax expense	$ 0	0.0
Tax cuts and jobs act of 2017 base erosion and anti abuse tax income tax expense	0	400,000
Change in valuation allowance, deferred tax asset	4,500,000	1,300,000
Deferred tax assets, valuation allowance	157,100,000	153,100,000
Tax cuts and jobs act, deferred tax assets	1,800,000	1,700,000
Tax cuts and jobs act, unremitted earnings of non-United States subsidiaries	255,300,000	322,000,000.0
Tax cuts and jobs act, additional unremitted earnings of non-United States subsidiaries	430,900,000
Change to gross unrecognized tax expense (benefits) including interest and penalties	1,700,000	7,600,000	$ 1,700,000
Uncertain tax liabilities interest and penalties	(300,000)	(1,000,000.0)	300,000
Uncertain tax liabilities interest and penalties accrued	6,400,000	6,700,000	7,700,000
Unrecognized tax benefits that would impact effective tax rate	7,200,000	7,200,000	$ 13,100,000
Domestic Tax Authority
Operating Loss Carryforwards [Line Items]
Interest expense carryforwards	$ 39,500,000
Maximum annual utilization percentage of interest expense carryforwards	30.00%
State and Local Jurisdiction
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 677,400,000
Operating loss carryforwards expiration period	2039
Non-U.S. Tax Authority
Operating Loss Carryforwards [Line Items]
Net operating loss carryforwards	$ 327,200,000
Net operating loss carryforwards, valuation allowance	160,100,000
U.K
Operating Loss Carryforwards [Line Items]
Deferred tax assets, valuation allowance	12,300,000
Non-U.S.
Operating Loss Carryforwards [Line Items]
Tax cuts and jobs act of 2017 change in net operating losses and valuation allowance	$ 19,900,000	$ 30,400,000

Income Taxes - Schedules of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Non-current deferred income tax assets (liabilities):
Inventories	$ 24.3	$ 22.7
Accounts receivable	(3.7)	(4.2)
Property, plant and equipment	(8.2)	(14.0)
Intangible assets	(34.1)	(34.8)
Deferred employee benefits	39.8	40.7
Product warranty reserves	8.6	6.6
Product liability reserves	3.0	4.0
Tax credits	5.4	7.1
Loss and other tax attribute carryforwards	125.7	137.8
Deferred revenue	5.8	5.1
Other	11.9	4.2
Total non-current deferred income tax assets	178.5	175.2
Less valuation allowance	(157.1)	(153.1)
Net deferred income tax assets, non-current	21.4	22.1
Components of Deferred Tax Assets and Liabilities [Abstract]
Long-term income tax assets, included in other non-current assets	26.9	27.8
Long-term deferred income tax liability	(5.5)	(5.7)
Net deferred income tax asset	$ 21.4	$ 22.1

Income Taxes - Schedule of Open Tax Years for Which the Company could be Subject to Income Tax Examination (Details)	12 Months Ended
	Dec. 31, 2019
United States \| Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2016
United States \| Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2019
China \| Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2009
China \| Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2019
France \| Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2016
France \| Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2019
Germany \| Earliest Tax Year
Income Tax Examination [Line Items]
Year under examination	2015
Germany \| Latest Tax Year
Income Tax Examination [Line Items]
Year under examination	2019

Income Taxes - Reconciliation of the Beginning and Ending Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 12.8	$ 19.5	$ 21.5
Additions based on tax positions related to the current year	0.5	0.3	0.9
Additions for tax positions of prior years	0.3	0.5	4.9
Reductions for tax positions of prior years	0.0	(1.7)	(0.5)
Reductions based on settlements with taxing authorities	(0.6)	(0.6)	(6.7)
Reductions for lapse of statute	(1.5)	(5.2)	(0.6)
Balance at end of year	$ 11.5	$ 12.8	$ 19.5

Earnings (Loss) Per Share - Narrative (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Earnings Per Share [Abstract]
Basic weighted average common shares outstanding	35,487,358	35,513,162	35,111,594
Number of anti-dilutive shares excluded from the calculation of diluted earnings per share	1,527,645	0	36,300

Earnings (Loss) Per Share - Reconciliation of the average shares outstanding used to compute basic and diluted earnings per share (Details) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Earnings Per Share [Abstract]
Basic weighted average common shares outstanding (in shares)	35,487,358	35,513,162	35,111,594
Effect of dilutive securities - stock awards (in shares)	154,442	0	743,308
Diluted weighted average common shares outstanding (in shares)	35,641,800	35,513,162	35,854,902

Equity - Narrative (Details) - USD ($)	12 Months Ended
Equity - Narrative (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Class Of Stock [Line Items]
Common stock, shares authorized (in shares)	75,000,000	75,000,000
Par value of common stock (in dollars per share)	$ 0.01
Preferred stock, shares authorized (in shares)	3,500,000	3,500,000
Par value of preferred stock per share (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)	0
Cash dividends declared or paid	$ 0	$ 0	$ 0
Common Stock
Class Of Stock [Line Items]
Common stock repurchased	7,400,000
Maximum \| Common Stock
Class Of Stock [Line Items]
Stock repurchase program, authorized amount	$ 30,000,000.0

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Equity [Abstract]
Foreign currency translation	$ (81.1)	$ (80.1)
Derivative instrument fair market value, net of income tax provision of $0.0 and $0.0		(0.3)
Employee pension and postretirement benefit adjustments, net of income benefit of $13.7 and $13.5	(39.9)	(36.2)
Total accumulated other comprehensive loss	$ (121.0)	$ (116.6)

- Definition

Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.

+ References + Details

Equity - Schedule of Components of Accumulated Other Comprehensive Loss (Parenthetical) (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Equity [Abstract]
Derivative instrument fair market value, tax provision	$ 0.0	$ 0.0
Employee pension and postretirement benefit adjustments, tax benefit	$ 13.7	$ 13.5

Equity - Reconciliation of accumulated other comprehensive loss (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	$ 601.3
Total other comprehensive income (loss), net of income tax	(4.4)	$ (19.2)	$ 65.5
Ending balance	645.9	601.3
Gains (Losses) on Cash Flow Hedges
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(0.3)	0.1
Other comprehensive income (loss) before reclassifications	(2.8)	(5.4)
Amounts reclassified from accumulated other comprehensive income	3.1	5.0
Total other comprehensive income (loss), net of income tax	0.3	(0.4)
Ending balance		(0.3)	0.1
Pension & Postretirement
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(36.2)	(45.1)
Other comprehensive income (loss) before reclassifications	(5.5)	3.5
Amounts reclassified from accumulated other comprehensive income	1.8	5.4
Total other comprehensive income (loss), net of income tax	(3.7)	8.9
Ending balance	(39.9)	(36.2)	(45.1)
Foreign Currency Translation
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(80.1)	(52.4)
Other comprehensive income (loss) before reclassifications	(1.0)	(27.7)
Total other comprehensive income (loss), net of income tax	(1.0)	(27.7)
Ending balance	(81.1)	(80.1)	(52.4)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Equity [Roll Forward]
Beginning balance	(116.6)	(97.4)
Other comprehensive income (loss) before reclassifications	(9.3)	(29.6)
Amounts reclassified from accumulated other comprehensive income	4.9	10.4
Total other comprehensive income (loss), net of income tax	(4.4)	(19.2)
Ending balance	$ (121.0)	$ (116.6)	$ (97.4)

Equity - Reconciliation of Reclassifications Out of Accumulated Other Comprehensive Income (Loss), Net of Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales	$ 383.1	$ 359.6	$ 409.5	$ 337.8	$ 426.1	$ 370.1	$ 404.8	$ 317.7	$ 1,490.0	$ 1,518.7	$ 1,299.4
Total before income taxes	11.3	21.2	49.9	(23.4)	(75.1)	0.8	8.7	(6.1)	59.0	(71.7)	(39.5)
Income tax provision	(2.1)	(3.1)	(3.9)	(3.3)	(3.2)	10.7	1.2	(3.9)	(12.4)	4.8	49.5
Net income (loss)	$ 9.2	$ 18.1	$ 46.0	$ (26.7)	$ (78.3)	$ 11.5	$ 9.7	$ (10.0)	46.6	(67.1)	9.4
Other expense - net									9.8	(11.5)	(6.8)
Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Net income (loss)									(4.9)	(10.4)	(0.4)
Gains and Losses on Cash Flow Hedges \| Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes									(3.1)	(5.0)	(0.7)
Net income (loss)									(3.1)	(5.0)	(0.7)
Gains and Losses on Cash Flow Hedges \| Reclassification out of Accumulated Other Comprehensive Income \| Foreign Currency Exchange Contracts
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Cost of sales									(3.1)	(5.0)	(0.7)
Actuarial Losses \| Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net									(4.6)	(5.0)	(5.2)
Amortization of Prior Service Cost \| Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net									2.8	2.7	1.3
Pension Settlement Charge \| Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Other expense - net										(4.5)
Pension & Postretirement \| Reclassification out of Accumulated Other Comprehensive Income
Schedule of Reclassifications out of Accumulated Comprehensive Income (Loss) [Line Items]
Total before income taxes									(1.8)	(6.8)	(3.9)
Income tax provision										1.4	4.2
Net income (loss)									$ (1.8)	$ (5.4)	$ 0.3

Stock-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Stock-Based Compensation
Share-based compensation, remaining shares available for issuance (in shares)	4,992,222
Period of U.S. Treasury rates as a basis for assumed risk-free rates (in years)	10 years
Engineering Selling and Administrative Expenses
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 9.5	$ 7.5	$ 6.3
Restricted Stock \| Other Expense
Stock-Based Compensation
Stock-based compensation expense (in dollars)		0.1
Restricted Stock \| Restructuring Charges
Stock-Based Compensation
Stock-based compensation expense (in dollars)		0.7	0.6
Stock Options
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 2.7	$ 2.4	$ 1.9
Number of share options granted during the period (in shares)	210,243	187,484	273,800
Weighted average grant date fair value, options (in dollars per share)	$ 8.07	$ 15.66	$ 12.16
Unrecognized compensation expense before income tax (in dollars)	$ 2.3
Recognition period for unrecognized compensation expense (in years)	1 year 3 months 18 days
Total intrinsic value of stock options exercised	$ 0.5	$ 1.1	$ 3.0
Stock Options \| Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Expiration period (in years)	10 years
Restricted Stock Units
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 3.4	$ 2.6	$ 3.1
Unrecognized compensation expense before income tax (in dollars)	$ 3.7
Recognition period for unrecognized compensation expense (in years)	1 year 7 months 6 days
Number of shares of other than options granted during the period (in shares)	229,044	111,713	152,855
Restricted Stock Units \| Employees
Stock-Based Compensation
Vesting period (in years)	3 years
Options vesting percentage	100.00%
Vesting rights, annual increments beginning on the grant date	100% on the third anniversary of the grant date
Anniversary period from grant date, for grants made prior to 2019 (in years)	3 years
Restricted Stock Units \| Non-employee Directors
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)	50,673	25,021	33,208
Vesting rights, annual increments beginning on the grant date	second anniversary
Performance Shares
Stock-Based Compensation
Stock-based compensation expense (in dollars)	$ 3.4	$ 2.5	$ 1.3
Period of U.S. Treasury rates as a basis for assumed risk-free rates (in years)	3 years
Unrecognized compensation expense before income tax (in dollars)	$ 4.3
Recognition period for unrecognized compensation expense (in years)	2 years
Number of shares of other than options granted during the period (in shares)	228,037	93,298	115,047
Performance period (in years)	3 years
Common stock, shares reserved for future issuance	87,642
2013 Omnibus Plan
Stock-Based Compensation
Share-based compensation, shares authorized (in shares)	7,477,395
Performance Shares 2019 \| Performance Shares
Stock-Based Compensation
Performance period (in years)	3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)	50.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)	50.00%
Performance Shares 2019 \| Performance Shares \| Minimum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)	0
Performance Shares 2019 \| Performance Shares \| Maximum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)	452,890
Performance Shares 2018 \| Performance Shares
Stock-Based Compensation
Performance period (in years)		3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)		50.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)		50.00%
Performance Shares 2018 \| Performance Shares \| Minimum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)		0
Performance Shares 2018 \| Performance Shares \| Maximum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)		179,770
Performance Shares 2017 \| Performance Shares
Stock-Based Compensation
Performance period (in years)			3 years
Percentage of shares paid based on total shareholder return relative to peer group (as a percent)			50.00%
Percentage of shares paid based on adjusted EBITDA (as a percent)			50.00%
Performance Shares 2017 \| Performance Shares \| Minimum
Stock-Based Compensation
Number of shares of other than options granted during the period (in shares)			87,642

Stock-Based Compensation - Summary of the Company's Stock Option Activity (Details) - Stock Options - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Shares
Options outstanding at the beginning of the period (in shares)	956,164
Granted (in shares)	210,243	187,484	273,800
Exercised (in shares)	(58,404)
Forfeited (in shares)	(17,164)
Canceled (in shares)	(24,868)
Options outstanding at the end of the period (in shares)	1,065,971	956,164
Options exercisable (in shares)	623,487
Weighted Average Exercise Price Per Share
Options outstanding at the beginning of the period (in dollars per share)	$ 21.58
Granted (in dollars per share)	18.40
Exercised (in dollars per share)	6.57
Options forfeited weighted average cost (in dollars per share)	23.81
Options canceled weighted average cost (in dollars per share)	21.18
Options outstanding at the end of the period (in dollars per share)	21.75	$ 21.58
Options exercisable (in dollars per share)	$ 20.96
Aggregate Intrinsic Value
Options outstanding (in dollars)	$ 0.4
Options exercisable (in dollars)	$ 0.4

Stock-Based Compensation - Schedule of the Assumptions Used to Estimate the Fair Value of Each Option Grant (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Stock Options
Assumptions used to estimate the fair value of each option grant
Expected life (years)	6 years 6 months	6 years 6 months	6 years 6 months
Risk-free Interest rate (as a percent)	2.60%	2.80%	2.20%
Expected volatility (as a percent)	39.80%	43.70%	45.00%
Performance Shares
Assumptions used to estimate the fair value of each option grant
Correlation (as a percent)	32.50%	29.50%	31.60%
Risk-free Interest rate (as a percent)	2.50%	2.40%	1.50%
Expected volatility (as a percent)	47.00%	33.80%	35.00%

Stock-Based Compensation - Schedule of Nonvested Share Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Restricted Stock Units
Shares
Unvested beginning balance (in shares)	219,917
Granted (in shares)	229,044	111,713	152,855
Vested (in shares)	(154,295)
Forfeited (in shares)	(4,103)
Unvested ending balance (in shares)	290,563	219,917
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value beginning (in dollars per share)	$ 25.37
Granted (in dollars per share)	18.39
Vested (in dollars per share)	20.26
Cancelled (in dollars per share)	27.34
Weighted average grant date fair value ending (in dollars per share)	$ 22.55	$ 25.37
Performance Shares
Shares
Unvested beginning balance (in shares)	337,124
Granted (in shares)	228,037	93,298	115,047
Vested (in shares)	(74,315)
Forfeited (in shares)	(78,441)
Unvested ending balance (in shares)	412,405	337,124
Weighted Average Grant Date Fair Value Per Share
Weighted average grant date fair value beginning (in dollars per share)	$ 28.02
Granted (in dollars per share)	22.01
Vested (in dollars per share)	25.73
Cancelled (in dollars per share)	20.24
Weighted average grant date fair value ending (in dollars per share)	$ 26.58	$ 28.02

Segments - Schedule of Information by Reportable Segment (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Net Sales	$ 463.4	$ 448.0	$ 504.7	$ 418.0	$ 515.3	$ 450.1	$ 495.3	$ 386.1	$ 1,834.1	$ 1,846.8	$ 1,581.3
Operating (loss) income	$ 17.8	$ 32.5	$ 41.9	$ 16.2	$ (62.0)	$ 16.9	$ 24.1	$ 1.7	108.4	(19.3)	8.4
Depreciation									35.0	36.1	38.1
Capital Expenditures									35.1	31.7	28.9
Segment Operating Income (Loss)
Segment Reporting Information [Line Items]
Operating (loss) income									139.8	22.1	45.0
Segment Operating Income (Loss) \| Americas
Segment Reporting Information [Line Items]
Net Sales									969.7	882.7	693.6
Operating (loss) income									113.4	58.8	6.8
Depreciation									14.5	14.0	15.1
Capital Expenditures									13.2	9.4	10.6
Segment Operating Income (Loss) \| Europe and Africa ("EURAF")
Segment Reporting Information [Line Items]
Net Sales									644.9	680.6	628.9
Operating (loss) income									3.8	(68.2)	5.1
Depreciation									15.1	15.3	15.0
Capital Expenditures									19.0	16.3	14.3
Segment Operating Income (Loss) \| Middle East and Asia Pacific ("MEAP")
Segment Reporting Information [Line Items]
Net Sales									219.5	283.5	258.8
Operating (loss) income									22.6	31.5	33.1
Depreciation									2.4	3.7	3.8
Capital Expenditures									2.9	3.4	3.9
Corporate
Segment Reporting Information [Line Items]
Operating (loss) income									(31.3)	(37.5)	(33.0)
Depreciation									$ 3.0	3.1	4.2
Capital Expenditures										$ 2.6	$ 0.1

Segments - Schedule of Reconciliation of the Company's Segment Operating Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)	$ 17.8	$ 32.5	$ 41.9	$ 16.2	$ (62.0)	$ 16.9	$ 24.1	$ 1.7	$ 108.4	$ (19.3)	$ 8.4
Restructuring expense									9.8	12.9	27.2
Segment Operating Income (Loss)
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)									139.8	22.1	45.0
Corporate
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)									(31.3)	(37.5)	(33.0)
Reconciliation of Company's Segment Operating Income
Segment Reporting Reconciling Item For Operating Profit Loss From Segment To Consolidated [Line Items]
Total operating income (loss)									108.4	(19.3)	8.4
Restructuring expense									$ (0.1)	$ (3.9)	$ (3.6)

Segments - Schedule of Net Sales and Property, Plant and Equipment by Geographic Area (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales	$ 463.4	$ 448.0	$ 504.7	$ 418.0	$ 515.3	$ 450.1	$ 495.3	$ 386.1	$ 1,834.1	$ 1,846.8	$ 1,581.3
Property, Plant and Equipment	289.9				288.9				289.9	288.9
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales									860.4	796.9	618.5
Property, Plant and Equipment	109.3				110.6				109.3	110.6
Europe
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales									619.8	659.9	601.3
Property, Plant and Equipment	150.4				145.2				150.4	145.2
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net Sales									353.9	390.0	$ 361.5
Property, Plant and Equipment	$ 30.2				$ 33.1				$ 30.2	$ 33.1

Segments - Schedule of Net Sales By Product (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Product Information [Line Items]
Total net sales	$ 463.4	$ 448.0	$ 504.7	$ 418.0	$ 515.3	$ 450.1	$ 495.3	$ 386.1	$ 1,834.1	$ 1,846.8	$ 1,581.3
Cranes
Product Information [Line Items]
Total net sales									1,498.6	1,509.9	1,270.5
Aftermarket Parts and Other
Product Information [Line Items]
Total net sales									$ 335.5	$ 336.9	$ 310.8

Commitments and Contingencies - Narrative (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Commitments And Contingencies [Line Items]
Period over which product liability self-insurance retention levels have fluctuated (in years)	10 years
Product liability reserves	$ 12,800,000	$ 16,300,000
Warranty claims reserves	48,600,000	$ 38,500,000
Gain on settlement	24,400,000
Other Income (Expense)
Commitments And Contingencies [Line Items]
Gain on settlement	15,500,000
Engineering, Selling and Administrative Expenses
Commitments And Contingencies [Line Items]
Gain on settlement	8,900,000
Maximum
Commitments And Contingencies [Line Items]
Product liability self-insurance maximum retention level for new occurrence	$ 2,000,000.0

Guarantees - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Guarantees - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Product Warranty Liability [Line Items]
Deferred revenue includes buybacks and extended warranties in accounts payable and accrued expenses and non-current liabilities	$ 38.0	$ 34.4
Amount of residual value guarantees and buyback commitments given by the company	$ 28.5	30.9
Standard product warranty, low end of range (in months)	12 months
Standard product warranty, high end of range (in months)	60 months
Other Noncurrent Liabilities
Product Warranty Liability [Line Items]
long-term warranty	$ 13.4	$ 8.7

Guarantees - Summary of Warranty Activity (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Warranty activity
Balance at beginning of period	$ 47.8	$ 44.5	$ 44.1
Accruals for warranties issued during the period	47.3	38.0	34.5
Settlements made (in cash or in kind) during the period	(34.2)	(33.8)	(36.9)
Currency translation	(0.3)	(0.9)	2.8
Balance at end of period	$ 60.6	$ 47.8	$ 44.5

Restructuring - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Restructuring - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 9.8	$ 12.9	$ 27.2
Employee Severance
Restructuring Cost and Reserve [Line Items]
Restructuring expense	$ 0.0
Tansfer of Crawler Production to Shady Grove, PA
Restructuring Cost and Reserve [Line Items]
Restructuring expense		$ 2.0
Closure of Manitowoc, WI Facility
Restructuring Cost and Reserve [Line Items]
Restructuring expense			$ 2.8

Restructuring - Summary of all restructuring activities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Summary of all restructuring accrual
Balance at beginning of period	$ 3.3	$ 5.6	$ 8.2
Restructuring expense	9.8	12.9	27.2
Use of reserve	(10.9)	(15.1)	(28.8)
Reserve reclassification	(0.2)		(1.2)
Currency translation		(0.1)	0.2
Balance at end of period	$ 2.0	$ 3.3	$ 5.6

Employee Benefit Plans - Narrative (Details) $ in Millions	1 Months Ended	12 Months Ended
Employee Benefit Plans - Narrative (Details) $ in Millions	Sep. 30, 2018 USD ($) Employee	Dec. 31, 2019 USD ($) plan	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan		$ 6.3	$ 6.2	$ 4.9
Defined Contribution Plan, Plan Name		Manitowoc 401(k) Retirement Plan	Manitowoc 401(k) Retirement Plan	Manitowoc 401(k) Retirement Plan
Other income (expense) - net		$ 9.8	$ (11.5)	$ (6.8)
Amortization of gains and losses in excess of specified percentage (as a percent)		10.00%
Postretirement Medical and Other
Manitowoc Deferred Compensation Plan
Annual rate of increase in the per capita cost of covered health care benefits assumed for measurement purposes (as a percent)		5.72%
Ultimate health care cost trend rate (as a percent)		4.50%
Estimated future employer contributions		$ 2.1
Final benefit payments		0.0	0.0
Supplemental Executive Retirement Plan
Manitowoc Deferred Compensation Plan
Final benefit payments		$ 2.5
Expenses related to retirement plan			0.2	1.2
Pension Settlement Charge \| Reclassification out of Accumulated Other Comprehensive Income
Manitowoc Deferred Compensation Plan
Other income (expense) - net			(4.5)
Deferred Compensation Plan
Manitowoc Deferred Compensation Plan
Number of investment programs \| plan		2
Deferred Compensation Plan \| Program A
Manitowoc Deferred Compensation Plan
Program asset		$ 0.5	0.2
Program obligation		0.5	0.2
Deferred Compensation Plan \| Program B
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan		0.5	0.3	0.0
Program asset		8.4	8.7
Program obligation		$ 8.4	8.7
U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Number of defined contribution retirement plans for the employees \| plan		2
Defined benefit plan obligation transfer	$ 18.6
Number of retirees and beneficiaries \| Employee	622
Estimated future employer contributions		$ 8.0
Final benefit payments		0.0	18.9
U.S. Pension Plans \| Pension Settlement Charge \| Reclassification out of Accumulated Other Comprehensive Income
Manitowoc Deferred Compensation Plan
Other income (expense) - net	$ 4.5
Non-U.S. Pension Plans
Manitowoc Deferred Compensation Plan
Total cost incurred under defined contribution plan		1.2	1.3	$ 1.5
Estimated future employer contributions		3.1
Final benefit payments		$ 0.0	$ 0.0

Employee Benefit Plans - Schedule of Components of Period Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
U.S. Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0.0	$ 0.0
Interest cost of projected benefit obligation	$ 5.1	$ 5.2
Weighted average assumptions:
Expected return on plan assets (as a percent)	5.20%	5.30%
Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 1.8	$ 1.8
Interest cost of projected benefit obligation	$ 2.2	$ 2.1
Weighted average assumptions:
Expected return on plan assets (as a percent)	3.50%	2.70%
Pension Plans \| U.S. Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0.0	$ 0.0	$ 0.0
Interest cost of projected benefit obligation	5.1	5.2	5.3
Expected return on assets	(4.3)	(5.7)	(4.9)
Amortization of prior service cost	0.0	0.0	0.0
Amortization of actuarial net loss (gain)	3.3	2.9	3.2
Pension settlement charge	0.0	4.5	0.0
Net periodic benefit cost	$ 4.1	$ 6.9	$ 3.6
Weighted average assumptions:
Discount rate (as a percent)	4.30%	3.80%	4.20%
Expected return on plan assets (as a percent)	5.20%	5.30%	4.70%
Rate of compensation increase (as a percent)	0.00%	0.00%	0.00%
Pension Plans \| Non-US Pension Plans
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 1.8	$ 1.8	$ 1.9
Interest cost of projected benefit obligation	2.2	2.1	2.1
Expected return on assets	(1.4)	(1.4)	(1.5)
Amortization of prior service cost	0.1	0.1	0.1
Amortization of actuarial net loss (gain)	1.3	1.3	1.6
Pension settlement charge	0.0	0.0	0.0
Net periodic benefit cost	$ 4.0	$ 3.9	$ 4.2
Weighted average assumptions:
Discount rate (as a percent)	2.50%	2.20%	2.10%
Expected return on plan assets (as a percent)	3.50%	2.70%	3.40%
Rate of compensation increase (as a percent)	3.60%	3.50%	2.60%
Postretirement Medical and Other
Components of periodic benefit costs
Service cost - benefits earned during the year	$ 0.2	$ 0.2	$ 0.3
Interest cost of projected benefit obligation	0.8	0.8	1.0
Expected return on assets	0.0	0.0	0.0
Amortization of prior service cost	(2.8)	(2.8)	(1.4)
Amortization of actuarial net loss (gain)	0.0	0.8	0.4
Pension settlement charge	0.0	0.0	0.0
Net periodic benefit cost	$ (1.8)	$ (1.0)	$ 0.3
Weighted average assumptions:
Discount rate (as a percent)	4.10%	3.30%	3.80%
Expected return on plan assets (as a percent)	0.00%	0.00%	0.00%
Rate of compensation increase (as a percent)	0.00%	0.00%	0.00%

Employee Benefit Plans - Reconciliation of the Changes in Benefit Obligation, Plan Assets, and Funded Status (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Change in Plan Assets
Fair value of plan assets, beginning of year	$ 125.0
Fair value of plan assets, end of year	144.8	$ 125.0
U.S. Pension Plans
Change in Benefit Obligation
Benefit obligation, beginning of year	130.5	162.3
Service cost	0.0	0.0
Interest cost	5.1	5.2
Participant contributions	0.0	0.0
Plan amendments	0.0	0.0
Actuarial (gain) loss	13.8	(9.2)
Currency translation adjustment	0.0	0.0
Pension settlement	0.0	(18.9)
Benefits paid	(7.1)	(8.8)
Benefit obligation, end of year	142.3	130.5	$ 162.3
Change in Plan Assets
Fair value of plan assets, beginning of year	84.9	116.2
Actual return on plan assets	16.8	(8.9)
Employer contributions	5.0	5.3
Participant contributions	0.0	0.0
Currency translation adjustment	0.0	0.0
Pension settlement	0.0	(18.9)
Benefits paid	(7.1)	(8.8)
Fair value of plan assets, end of year	99.6	84.9	116.2
Funded status	(42.7)	(45.6)
Amounts recognized in the Consolidated Balance sheet at December 31
Pension asset	0.0	0.0
Pension obligation	(42.7)	(45.6)
Postretirement medical and other benefit obligations	0.0	0.0
Net amount recognized	$ (42.7)	$ (45.6)
Weighted-Average Assumptions
Discount rate	3.30%	4.30%
Expected return on plan assets (as a percent)	5.20%	5.30%
Rate of compensation increase	0.00%	0.00%
Non-US Pension Plans
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 81.9	$ 89.5
Service cost	1.8	1.8
Interest cost	2.2	2.1
Participant contributions	0.0	0.0
Plan amendments	0.0	0.0
Actuarial (gain) loss	8.3	(3.0)
Currency translation adjustment	1.1	(4.6)
Pension settlement	0.0	0.0
Benefits paid	(4.7)	(3.9)
Benefit obligation, end of year	90.6	81.9	89.5
Change in Plan Assets
Fair value of plan assets, beginning of year	40.1	45.1
Actual return on plan assets	4.2	(1.4)
Employer contributions	4.0	2.8
Participant contributions	0.0	0.0
Currency translation adjustment	1.6	(2.5)
Pension settlement	0.0	0.0
Benefits paid	(4.7)	(3.9)
Fair value of plan assets, end of year	45.2	40.1	45.1
Funded status	(45.4)	(41.8)
Amounts recognized in the Consolidated Balance sheet at December 31
Pension asset	0.0	0.0
Pension obligation	(45.4)	(41.8)
Postretirement medical and other benefit obligations	0.0	0.0
Net amount recognized	$ (45.4)	$ (41.8)
Weighted-Average Assumptions
Discount rate	1.50%	2.20%
Expected return on plan assets (as a percent)	3.50%	2.70%
Rate of compensation increase	3.60%	3.50%
Postretirement Medical and Other
Change in Benefit Obligation
Benefit obligation, beginning of year	$ 20.7	$ 28.9
Service cost	0.2	0.2	0.3
Interest cost	0.8	0.8	1.0
Participant contributions	0.4	0.7
Plan amendments	0.0	0.0
Actuarial (gain) loss	(1.5)	(7.2)
Currency translation adjustment	0.0	0.0
Pension settlement	0.0	0.0
Benefits paid	(2.2)	(2.7)
Benefit obligation, end of year	18.4	20.7	28.9
Change in Plan Assets
Fair value of plan assets, beginning of year	0.0	0.0
Actual return on plan assets	0.0	0.0
Employer contributions	1.8	2.0
Participant contributions	0.4	0.7
Currency translation adjustment	0.0	0.0
Pension settlement	0.0	0.0
Benefits paid	(2.2)	(2.7)
Fair value of plan assets, end of year	0.0	0.0	$ 0.0
Funded status	(18.4)	(20.7)
Amounts recognized in the Consolidated Balance sheet at December 31
Pension asset	0.0	0.0
Pension obligation	0.0	0.0
Postretirement medical and other benefit obligations	(18.4)	(20.7)
Net amount recognized	$ (18.4)	$ (20.7)
Weighted-Average Assumptions
Discount rate	2.90%	4.10%
Expected return on plan assets (as a percent)	0.00%	0.00%	0.00%
Rate of compensation increase	0.00%	0.00%

Employee Benefit Plans - Amounts Recognized in Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	$ (61.9)	$ (59.3)
Prior service credit (cost)	(0.5)	(0.5)
Total amount recognized	(62.4)	(59.8)
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
Net actuarial gain (loss)	1.9	0.4
Prior service credit (cost)	6.9	9.7
Total amount recognized	$ 8.8	$ 10.1

Employee Benefit Plans - Summary of the Sensitivity of Retirement Obligations and Retirement Benefit Costs of Plans to Changes in the Key Assumptions (Details) $ in Millions	12 Months Ended
	Dec. 31, 2019 USD ($)
Pension Plans
Estimated increase (decrease) in 2020 pension cost
0.50% increase in discount rate	$ (0.8)
0.50% decrease in discount rate	0.9
0.50% increase in long-term return on assets	(0.7)
0.50% decrease in long-term return on assets	0.7
Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	(14.3)
0.50% decrease in discount rate	15.7
Postretirement Medical and Other
Estimated increase (decrease) in 2020 pension cost
0.50% decrease in discount rate	(0.1)
1% decrease in medical trend rates	(0.1)
Estimated increase (decrease) in Projected Benefit Obligation for the year ended December 31, 2019
0.50% increase in discount rate	(0.6)
0.50% decrease in discount rate	0.6
1% increase in medical trend rates	0.7
1% decrease in medical trend rates	$ (0.6)

Employee Benefit Plans - Schedule of the Weighted-Average Asset Allocations of the Pension Plans (Details)	Dec. 31, 2019	Dec. 31, 2018
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	100.00%	100.00%
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	100.00%	100.00%
Equity Securities \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	50.40%	47.80%
Equity Securities \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	0.00%	36.10%
Fixed Income \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	48.90%	51.40%
Fixed Income \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	31.90%	31.60%
Other \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	0.70%	0.80%
Other \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent), Total	68.10%	32.30%

Employee Benefit Plans - Schedule of the Actual Allocations for the Pension Assets and Target Allocations by Asset Class (Details)	Dec. 31, 2019	Dec. 31, 2018
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)	100.00%	100.00%
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Weighted-average asset allocation (as a percent)	100.00%	100.00%
Equity Securities \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	50.00%
Weighted-average asset allocation (as a percent)	50.40%	47.80%
Equity Securities \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	0.00%
Weighted-average asset allocation (as a percent)	0.00%	36.10%
Debt Securities \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	50.00%
Weighted-average asset allocation (as a percent)	48.90%
Debt Securities \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	40.00%
Weighted-average asset allocation (as a percent)	31.90%
Other \| U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	0.00%
Weighted-average asset allocation (as a percent)	0.70%	0.80%
Other \| Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Target Allocations (as a percent)	60.00%
Weighted-average asset allocation (as a percent)	68.10%	32.30%

Employee Benefit Plans - Schedule of Plan Assets Using the Fair Value Hierarchy (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 144.8	$ 125.0
Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	129.8	111.3
Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.4	1.7
Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12.6	12.0
Cash and Cash Equivalents
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.4	1.7
Cash and Cash Equivalents \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Cash and Cash Equivalents \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.4	1.7
Cash and Cash Equivalents \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Cash and Cash Equivalents \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Insurance Group Annuity Contracts
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12.6	12.0	$ 14.4
Insurance Group Annuity Contracts \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Insurance Group Annuity Contracts \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Insurance Group Annuity Contracts \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Insurance Group Annuity Contracts \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	12.6	12.0
Common/Collective Trust Funds — Corporate and Other Non-government Debt
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	22.9
Common/Collective Trust Funds — Corporate and Other Non-government Debt \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	22.9
Common/Collective Trust Funds — Corporate and Other Non-government Debt \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Corporate and Other Non-government Debt \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Corporate and Other Non-government Debt \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Government, Corporate and Other Non-government Debt
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	40.2	56.3
Common/Collective Trust Funds — Government, Corporate and Other Non-government Debt \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	40.2	56.3
Common/Collective Trust Funds — Government, Corporate and Other Non-government Debt \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Common/Collective Trust Funds — Government, Corporate and Other Non-government Debt \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Common/Collective Trust Funds — Government, Corporate and Other Non-government Debt \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Common/Collective Trust Funds — Customized Strategy
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	16.4
Common/Collective Trust Funds — Customized Strategy \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	16.4
Common/Collective Trust Funds — Customized Strategy \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Customized Strategy \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Customized Strategy \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0
Common/Collective Trust Funds — Corporate Equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	50.3	55.0
Common/Collective Trust Funds — Corporate Equity \| Net Asset Value ("NAV")
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	50.3	55.0
Common/Collective Trust Funds — Corporate Equity \| Quoted Prices in Active Markets for Identical Assets (Level 1)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Common/Collective Trust Funds — Corporate Equity \| Significant Other Observable Inputs (Level 2)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.0	0.0
Common/Collective Trust Funds — Corporate Equity \| Unobservable Inputs (Level 3)
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0.0	$ 0.0

Employee Benefit Plans - Reconciliation of the Fair Values Measurements of Plan Assets Using Significant Unobservable Inputs (Level 3) from the Beginning of the Year to the End of the Year (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	$ 125.0
Fair value of plan assets, end of year	144.8	$ 125.0
Insurance Group Annuity Contracts
Reconciliation of fair value measurements of plan assets using significant observable inputs
Fair value of plan assets, beginning of year	$ 12.0	$ 14.4
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]	us-gaap:FairValueInputsLevel3Member	us-gaap:FairValueInputsLevel3Member
Actual return on assets	$ 1.1	$ (0.3)
Benefit payments	(1.0)	(1.3)
Foreign currency impact	0.5	(0.8)
Fair value of plan assets, end of year	$ 12.6	$ 12.0
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]	us-gaap:FairValueInputsLevel3Member	us-gaap:FairValueInputsLevel3Member

Employee Benefit Plans - Schedule of Projected Future Benefit Payments from the Plans (Details) $ in Millions	Dec. 31, 2019 USD ($)
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2020	$ 8.5
2021	8.6
2022	8.7
2023	8.8
2024	8.8
Thereafter	43.0
Total	86.4
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
2020	3.1
2021	2.9
2022	3.1
2023	3.5
2024	3.6
Thereafter	21.1
Total	37.3
Postretirement Medical and Other
Defined Benefit Plan Disclosure [Line Items]
2020	2.1
2021	2.0
2022	1.9
2023	1.8
2024	1.7
Thereafter	6.6
Total	$ 16.1

Employee Benefit Plans - Schedule of Fair Value of Plan Assets for Which the Accumulated Benefit Obligation is in Excess of the Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 142.3	$ 130.5
Accumulated benefit obligation	142.3	130.5
Fair value of plan assets	99.6	84.9
Non-U.S. Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	90.5	81.9
Accumulated benefit obligation	86.4	78.1
Fair value of plan assets	$ 45.2	$ 40.1

Leases - Narrative (Details) $ in Millions	12 Months Ended
Leases - Narrative (Details) $ in Millions	Dec. 31, 2019 USD ($)
Leases [Line Items]
Lease, practical expedients, package	true
Operating leases, existence of option to extend	true
Operating leases, existence of option to terminate	true
Operating leases, termination term	1 year
Cash payment for operating leases	$ 27.4
Operating leases, weighted-average remaining lease term	7 years 3 months 18 days
Operating leases, weighted-average discount rate	4.66%
Maximum
Leases [Line Items]
Operating leases, remaining lease term	24 years
Operating leases, renewal lease term	10 years

Leases - Summary of Components of Lease Expense (Details) $ in Millions	12 Months Ended
	Dec. 31, 2019 USD ($)
Leases [Abstract]
Operating lease cost	$ 14.4
Variable lease cost	1.4
Total lease cost	$ 15.8

Leases - Summary of Supplemental Consolidated Balance Sheet Information Related to Leases (Details) $ in Millions	Dec. 31, 2019 USD ($)
Leases [Abstract]
Operating lease right-of-use assets	$ 47.6
Other liabilities	$ 10.4
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	us-gaap:OtherLiabilitiesCurrent
Operating lease liabilities	$ 37.6
Total operating lease liabilities	$ 48.0

Leases - Summary of Maturities of Operating Lease Liabilities (Details) $ in Millions	Dec. 31, 2019 USD ($)
Leases [Abstract]
2020	$ 12.1
2021	10.2
2022	8.3
2023	6.0
2024	4.5
Thereafter	16.5
Total lease payments	57.6
Less: imputed interest	(9.6)
Present value of lease liabilities	$ 48.0

Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Data (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]
Net sales	$ 463.4	$ 448.0	$ 504.7	$ 418.0	$ 515.3	$ 450.1	$ 495.3	$ 386.1	$ 1,834.1	$ 1,846.8	$ 1,581.3
Cost of sales	383.1	359.6	409.5	337.8	426.1	370.1	404.8	317.7	1,490.0	1,518.7	1,299.4
Gross profit	80.3	88.4	95.2	80.2	89.2	80.0	90.5	68.4	344.1	328.1	281.9
Operating (loss) income	17.8	32.5	41.9	16.2	(62.0)	16.9	24.1	1.7	108.4	(19.3)	8.4
Income (loss) from continuing operations before income taxes	11.3	21.2	49.9	(23.4)	(75.1)	0.8	8.7	(6.1)	59.0	(71.7)	(39.5)
Provision (benefit) for income taxes	2.1	3.1	3.9	3.3	3.2	(10.7)	(1.2)	3.9	12.4	(4.8)	(49.5)
Net income (loss) from continuing operations	9.2	18.1	46.0	(26.7)	(78.3)	11.5	9.9	(10.0)	46.6	(66.9)	10.0
Loss from discontinued operations, net of income taxes							(0.2)			(0.2)	(0.6)
Net income (loss)	$ 9.2	$ 18.1	$ 46.0	$ (26.7)	$ (78.3)	$ 11.5	$ 9.7	$ (10.0)	$ 46.6	$ (67.1)	$ 9.4
Basic (loss) income per share:
Net income (loss) income from continuing operations	$ 0.26	$ 0.51	$ 1.29	$ (0.75)	$ (2.20)	$ 0.32	$ 0.28	$ (0.28)	$ 1.31	$ (1.88)	$ 0.28
Loss from discontinued operations							(0.01)		0	(0.01)	(0.02)
Basic net income (loss) per share	0.26	0.51	1.29	(0.75)	(2.20)	0.32	0.27	(0.28)	1.31	(1.89)	0.26
Diluted (loss) income per share:
Net income (loss) from continuing operations	0.26	0.51	1.29	(0.75)	(2.20)	0.32	0.27	(0.28)	1.31	(1.88)	0.28
Loss from discontinued operations									0	(0.01)	(0.02)
Diluted net income (loss) per share	$ 0.26	$ 0.51	$ 1.29	$ (0.75)	$ (2.20)	$ 0.32	$ 0.27	$ (0.28)	$ 1.31	$ (1.89)	$ 0.26

Schedule II: Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Allowance for Doubtful Accounts
Valuation and Qualifying Accounts
Balance at Beginning of Year	$ 10.3	$ 10.9	$ 11.1
Charge to Costs and Expenses	1.4	2.6	1.7
Utilization of Reserve	(3.9)	(2.4)	(2.7)
Other, Primarily Impact of Foreign Exchange Rates	0.2	(0.8)	0.8
Balance at end of Year	7.9	10.3	10.9
Deferred Tax Valuation Allowance
Valuation and Qualifying Accounts
Balance at Beginning of Year	153.1	162.3	269.6
Charge to Costs and Expenses	11.7	14.4	15.2
Utilization of Reserve	(7.2)	(13.1)	(128.7)
Other, Primarily Impact of Foreign Exchange Rates	(0.5)	(10.5)	6.2
Balance at end of Year	$ 157.1	$ 153.1	$ 162.3